Podcasts about Grouse

Subfamily of birds

  • 368PODCASTS
  • 1,051EPISODES
  • 53mAVG DURATION
  • 5WEEKLY NEW EPISODES
  • Sep 16, 2025LATEST
Grouse

POPULARITY

20172018201920202021202220232024

Categories



Best podcasts about Grouse

Show all podcasts related to grouse

Latest podcast episodes about Grouse

Wildlife Photo Chat
238: Levi Fitze

Wildlife Photo Chat

Play Episode Listen Later Sep 16, 2025 62:42


My guest Levi Fitze joins me to discuss wrapping up shooting on his multi-year project about Grouse in the Alps, we talk about where his love of the mountains and harsh weather came from, and his focus on capturing images that move people and tell a story and how to go about doing that. Follow Levi Fitze at: Instagram: @levifitze Show Mentions: Vincent Munier

Dozing Off | Deep Voice ASMR Bedtime Stories

In tonight's sleep story, I narrated, The Enchanted Grouse by Parker Fillmore. Thank you for being part of the Dozing Off community!If you're interested in supporting the show and getting an additional story each week, check out Dozing Off on Patreon:patreon.com/dozingoffpodcast

Continuum Audio
Ataxia With Dr. Theresa Zesiewicz

Continuum Audio

Play Episode Listen Later Sep 10, 2025 20:31


Ataxia is a neurologic symptom that refers to incoordination of voluntary movement, typically causing gait dysfunction and imbalance. Genetic testing and counseling can be used to identify the type of ataxia and to assess the risk for unaffected family members. In this episode, Katie Grouse, MD, FAAN, speaks with Theresa A. Zesiewicz, MD, FAAN, author of the article “Ataxia” in the Continuum® August 2025 Movement Disorders issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California San Francisco in San Francisco, California. Dr. Zesiewicz is a professor of neurology and director at the University of South Florida Ataxia Research Center, and the medical director at the University of South Florida Movement Disorders Neuromodulation Center at the University of South Florida and at the James A. Haley Veteran's Hospital in Tampa, Florida. Additional Resources Read the article: Ataxia Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Grouse: This is Dr Katie Grouse. Today I'm interviewing Dr Theresa Zesiewicz about her article on ataxia, which appears in the August 2025 Continuum issue on movement disorders. Welcome to the podcast, and please introduce yourself to our audience.  Dr Zesiewicz: Well, thank you, Dr Grouse. I'm Dr Theresa Zesiewicz, otherwise known as Dr Z, and I'm happy to be here. Dr Grouse: I have to say, I really enjoyed reading your article. It was a really great refresher for myself as a general neurologist on the topic of ataxia and a really great reminder on a great framework to approach diagnosis and management. But I wanted to start off by asking what you feel is the key message that you hope our listeners will take away from reading your article. Dr Zesiewicz: Yes, so, thanks. I think one of the key messages is that there has been an explosion and renaissance of genetic testing in the past 10 years that has really revolutionized the field of ataxia and has made diagnosis easier for us, more manageable, and hopefully will lead to treatments in the future. So, I think that's a major step forward for our field in terms of genetic techniques over the last 10 years, and even over the last 30 years. There's just been so many diseases that have been identified genetically. So, I think that's a really important take-home message. The other take-home message is that the first drug to treat Friedreich's ataxia, called omaveloxolone, came about about two years ago. This was also a really landmark discovery. As you know, a lot of these ataxias are very difficult to treat. Dr Grouse: Now pivoting back to thinking about the approach to diagnosis of ataxia, how does the timeline of the onset of ataxia symptoms inform your approach? Dr Zesiewicz: The timeline is important because ataxia can be acute, subacute or chronic in nature. And the timeline is important because, if it's acute, it may mean that the ataxia took place over seconds to hours. This may mean a toxic problem or a hypoxic problem. Whereas a chronic ataxia can occur over many years, and that can inform more of a neurodegenerative or more of a genetic etiology. So, taking a very detailed history on the patient is very important. Sometimes I ask them, what is the last time you remember that you walked normal? And that can be a wedding, that can be a graduation. Just some timeline, some point, that the patient actually walked correctly before they remember having to hold onto a railing or taking extra steps to make sure that they didn't fall down, that they didn't have imbalance. That sometimes that's a good way to ask the patient when is the last time they had a problem. And they can help you to try to figure out how long these symptoms have been going on. Dr Grouse: I really appreciate that advice. I will say that I agree, it can sometimes be really hard to get patients to really think back to when they really started to notice something was different. So, I like the idea of referencing back to a big event that may be more memorable to them. Now, given that framework of, you know, thinking through the timeline, could you walk us through your approach to the evaluation of a patient who presents to your clinic with that balance difficulties once you've established that? Dr Zesiewicz: Sure. So, the first thing is to determine whether the patient truly has ataxia. So, do they have imbalance? Do they have a wide base gait? That's very important because patients come in frequently to your clinic and they'll have balance problems, but they can have knee issues or hip issues, neuropathy, something like that. And sometimes what we say to the residents and the students is, usually ataxia or cerebellar symptoms go together with other problems, like ocular problems are really common in cerebellar syndromes. Or dysmetria, pass pointing, speech disorder like dysarthria. So, not only do you need to look at the gait, but you should look at the other symptoms surrounding the gait to see if you think that the patient actually has a cerebellar syndrome. Or do they have something like a vestibular ataxia which would have more vertigo? Or do they have a sensory ataxia, which would occur if a person closes his eyes or has more ataxia when he or she is in the dark? So, you have to think about what you're looking at is the cerebellar syndrome. And then once we look to see if the patient truly has a cerebellar syndrome, then we look at the age, we look at---as you said before, the timeline. Is this acute, subacute, or chronic? And usually I think of ataxia as falling into three categories. It's either acquired, it's either hereditary, or it's neurodegenerative. It can be hereditary. And if it's not hereditary, is it acquired, or is it something like a multiple system atrophy or a parkinsonism or something like that? So, we try to put that together and start to narrow down on the diagnosis, thinking about those parameters. Dr Grouse: That's really a helpful way to think through it. And it is true, it can get very complex when patients come in with balance difficulties. There's so many things you need to think about, but that is a great way to think about it. Of course, we know that most people who come in to the Movements Disorders clinic are getting MRI scans of their brains. But I'm curious, in which cases of patients with cerebellar ataxia do you find the MRI to be particularly helpful in the diagnosis? Dr Zesiewicz: So, an MRI can be very important. Not always, but- so, something like multiple system atrophy type C where you may see a hot cross bun sign or a pontine hyperintensity on the T2-weighted image, that would be helpful. But of course, that doesn't make the diagnosis. It's something that may help you with the diagnosis. In FXTAS, which is fragile X tremor/ataxia syndrome, the patient may have the middle cerebellar peduncle sign or the symmetric hyperintensity in the middle cerebellar peduncles, which is often visible but not always. Something like Wernicke's, where you see an abnormality of the mammillary bodies. Wilson's disease, which is quite rare, T2-weighted image may show hyperintensities in the putamen in something like Wilson's disease. Those are the main MRI abnormalities, I think, with ataxia. And then we look at the cerebellum itself. I mean, that seems self-evident, but if you look at a sagittal section of the MRI and you see just a really significant atrophy of the cerebellum, that's going to help you determine whether you really have a cerebellar syndrome. Dr Grouse: That's really encouraging to hear a good message for all of us who sometimes feel like maybe we're missing something. It's good to know that information can always come up down the line to make things more clear. Your article does a great review of spinal cerebellar ataxia, but I found it interesting learning about the more recently described syndrome of SCA 27B. Would you mind telling us more about that and other really common forms of SCA that's good to keep in mind? Dr Zesiewicz: Sure. So, there are now 49 types of spinal cerebellar ataxia that have been identified. The most common are the polyglutamine repeat diseases: so, spinocerebellar ataxia type 3 or type 2, type 6, are probably the most common. One of the most recent spinocerebellar ataxias to be genetically identified and clinically identified is spinocerebellar ataxia 27B. This is caused by a GAA expansion repeat in the first intron of the fibroblast growth factor on chromosome 13. And the symptoms do include ataxia, eye problems, downbeat nystagmus, other nystagmus, vertical, and diplopia. It appears to be a more common form of adult-onset ataxia, and probably more common than was originally thought. It may account for a substantial number of ataxias, like, a substantial percentage of ataxias that we didn't know about. So, this was really a amazing discovery on SCA 27B. Dr Grouse: Now a lot of us I think feel a little anxious when we think about genetic testing for ataxia simply because there's so many forms, things are changing quickly. Do you have a rule of thumb or a kind of a framework that we can think of as we approach how we should be thinking about getting genetic testing for the subset of patients? Dr Zesiewicz: Sure. And I think that this is where age comes into play a lot. So, if you have a child who's 10, 11, or 12 who's having balance problems in the schoolyard, does not have a history of ataxia in the family, the teachers are telling you that the child is not running correctly, they're having problems with physical education, that is someone who you would think about testing for Friedreich's ataxia. A preteen or a child, that would be one thing that would be important to test. When you talk to your patient, it's important to really take a detailed family history. Not just mom or dad, but ethnicity, grandparents, etc. And sometimes, once in a while, you come up with a known spinal cerebellar ataxia. Then you can just test for that. So, if a person is from Portugal or has Portugal background and they have ataxia and the parents had ataxia, you would think of spinal cerebellar ataxia type 3. Or if they're Brazilian, or if the person is from a certain area of Cuba and mom and dad had ataxia and that person has ataxia, you would think of spinal cerebellar ataxia type 2. Or if a person has ataxia and their parent had blindness or visual problems, you may be more likely to think of spinal cerebellar ataxia type 7, for example. If they have that---either they have a known genetic cause in in the family, first degree family, or they come from an area of the world in which we can pinpoint what type we think it is---you can go ahead and get those tests. If not, you can take an ataxia comprehensive panel. Many times now, if you take the panel and the panel is negative, it will reflex to the whole exome gene sequencing, where we're finding really unusual and more rare types of ataxia, which are very interesting. Spinal cerebellar ataxia type 32, spinal cerebellar ataxia type 36, I had a spinal cerebellar ataxia type 15. So, I think you should start with the age, then the family history, then where the person is from. And then, if none of those work out, you can get a comprehensive panel, and then go on to whole exome gene sequencing. Dr Grouse: That's really, really useful. Thank you so much for breaking that down in a really simple way that a lot of us can take with us. Pivoting a little bit now back towards different types of acquired ataxias, what are some typical lab tests that you recommend for that type of workup? Dr Zesiewicz: Again, if there's no genetic history and the person does not appear to have a neurodegenerative disease, we do test for acquired ataxias. Acquired ataxias can be complex. Many times, they are in the autoimmune family. So, what we start with are just basic labs like a CBC or a CMP, but then we tried to look at some of the other abnormalities that could cause ataxia. So, celiac disease, stiff person syndrome. So, you would look at anti-glutamic acid decarboxylase antibodies, Hashimoto's---so, antithyroglobulin antibodies or antithyroperoxidase antibodies would be helpful. You know, in a case of where the patients may have an underlying neoplasm, maybe even a paraneoplastic workup, such as an anti-Hu, anti-Yo, anti-Ri. A person has breast cancer, for example, you may want to take a paraneoplastic panel. I've been getting more of the anti-autoimmune encephalitis panels in some cases, that were- that are very interesting. And then, you know, things that sometimes we forget now like the syphilis test, thyroid-stimulating test, take a B12 and folate, for example. That would be important. Those are some of the labs. We just have on our electronic chart a group of acquired labs for ataxia. If we can't find any other reason, we just go ahead and try to get those. Dr Grouse: Now, I'm curious what you think is the most challenging aspect of diagnosing a patient with cerebellar ataxia? Dr Zesiewicz: So, for those of us who see many of these patients a day, some of the hardest patients are the ones that---regardless of the workup that we do, we've narrowed it down, it's not hereditary. You know, they've been through the whole exome gene sequencing and we've done the acquired ataxia workup. It doesn't appear to be that. And then we've looked for parkinsonism and neurodegenerative diseases, and it doesn't appear to be that either; like, the alpha-synuclein will be negative. Those are the toughest patients, where we think we've done everything and we still don't have the answer. So, I've had patients in whom I've taken care of family members years and years ago, they had a presumed diagnosis, and later on I've seen their children or other family members. And with the advent of the genetic tests that we have, like whole exome gene sequencing, we have now been able to give the patient and the family a definitive diagnosis that they didn't have 25 years ago. So, I would say don't give up hope. Retesting is important, and as science continues and we get more information and we make more landmark discoveries in genetics, you may be better able to diagnose the patient. Dr Grouse: I was wondering if you had any recommendations regarding either some tips and tricks, some pearls of wisdom you can impart to us regarding the work of ataxia, or conversely, any big pitfalls that you can help us avoid? I would love to hear about it. Dr Zesiewicz: Yeah, there's no easy way to treat or diagnose ataxia patients. I've always felt that the more patients you see- and sounds easy, but the more patients you see, the better you're going to become at it, and eventually things are going to fall into place. You'll begin to see similarities in patients, etc. I think it's important not only to make sure that a person has ataxia, but again, look at the other signs and symptoms that may point to ataxia that you'll see in a cerebellar syndrome. I think it's important to do a full neuroexam. If a person has spasticity, that may point you more towards a certain type of ataxia than if a person has no reflexes, for example, that we see in Friedreich's ataxia. Some of the ocular findings are very interesting as well. It's important to know if a person has a tremor. I've seen several Wilson's disease cases in my life with ataxia. They're very important. I think a full neuroexam and also a very detailed history would be very helpful. Dr Grouse: Tell us about some promising developments in the diagnosis and management of ataxia that we should be on the lookout for. Dr Zesiewicz: The first drug for Friedreich's ataxia was FDA-approved two years ago, which was an NRF2 activator, which was extremely exciting and promising. There are also several medications that are now in front of the FDA that may also be very promising and have gone through long clinical trials. There's a medication that's related to riluzole, which is a medication used for amyotrophic lateral sclerosis, that has been through about seven years of testing. That is before the FDA as well for spinal cerebellar ataxia. Friedreich's ataxia has now completed the first cardiac gene therapy program with AAV vectors, which- we're waiting for full results, but that's a cardiac test. But I would assume that in the future, neurological gene therapy is not far behind if we've already done cardiac gene therapy and Friedreich's ataxia. So, you know, some of these AAV vector-based genetic therapies may be very helpful, as well as ASO, antisense oligonucleotides, for example. And I think in the future, other things to think about are the CRISPR/Cas9 technology for potential treatment of ataxia. It is a very exciting time, and some major promising therapies have been realized in the past 2 to 3 years. Dr Grouse: Well, that's really exciting, and we'll all look forward to seeing these becoming more clinically applicable in the future. So, thank you so much for coming to talk with us today. Dr Zesiewicz: Thank you. Dr Grouse: Again, today I've been interviewing Dr Theresa Zesiewicz about her article on ataxia, which appears in the August 2025 Continuum issue on movement disorders. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

The Flush Podcast - Stories from the field

Tom Carpenter from Pheasants Forever & Quail Forever joins the show to break down the 2025 prairie grouse primer presented by Sportsman's Guide.  We break down sharp-tailed grouse, sage grouse, Hungarian partridge, and prairie chicken hunting expectations by region, from Idaho to Minnesota and places in between.  We discuss factors that raised bird counts in some places, and lowered counts in others.  We share details that can make or break your next hunt on the prairie and throw in a few tricks to outsmart those wild birds.  It's a full prairie grouse primer, with even more information @pheasantsforever   Presented by: Walton's (waltons.com/) OnX Maps (onxmaps.com/) Aluma Trailers (alumaklm.com) GAIM Hunting & Shooting Simulator (https://alnk.to/74wKReb) Compeer Home (compeerhome.com) Federal Premium Ammunition (federalpremium.com/) Hunt North Dakota (helloND.com/) Lucky Duck Premium Decoys (luckyduck.com/) & Samaritan Tire (samaritantire.com/)

Vortex Nation Podcast
Ep. 409 | Grouse Biology and More with Meadow Kouffeld

Vortex Nation Podcast

Play Episode Listen Later Sep 1, 2025 86:21


Ecologist, guide, dog trainer, and taxidermist, Meadow Kouffeld, gives us a rundown on Ruffed Grouse biology and their habits. Knowing your quarry isn't just interesting, it will make you a better hunter. Quit grousing around and tune in for some great grouse info.As always, we want to hear your feedback! Let us know if there are any topics you'd like covered on the Vortex Nation™ podcast by asking us on Instagram @vortexnationpodcast

Overdrive Outdoors Podcast
Aspen Thicket Grouse Dogs- Dennis Stachewicz

Overdrive Outdoors Podcast

Play Episode Listen Later Aug 28, 2025 115:01


This week, Kevin talks with the owner of Aspen Thicket Grouse Dogs, Dennis Stachewicz. This episode focuseses on Dennis's background, including his military service and current role as Community Development Director in Michigan's Upper Peninsula, along with his experiences in hunting and breeding German shorthair pointers. Dennis shared detailed insights about his dog training and breeding program, hunting techniques, and experiences with grouse populations and habitat management in the region. The conversation concluded with discussions about wolf encounters, hunting experiences, and the importance of preserving hunting and fishing traditions for future generations. https://www.aspenthicketgrousedogs.com/ As always, THANK YOU for listening! Predator Thermal Optics code "ptothermal" for 10% off all Predator Thermal Optics brand Scopes and Monoculars www.predatorthermaloptics.com www.predatorhunteroutdoors.com code: tripod for 10% off tripods and mounts code: light for 20% off lighting products Predator Hunter Outdoors ATN Prym1 Wiebe Knives- code "OVERDRIVE15" for 15% off you entire order High Pressure Pneumatics Razor Broadheads- code "Overdrive10" for 10% off your order

Upland Nation
Pro bird hunting guide's strategies, tactics for grouse & woodcock, Gordon Setters and being a good client

Upland Nation

Play Episode Listen Later Aug 26, 2025 80:27


Grouse, woodcock, training during the hunt, and a short history of Gordon Setters ... those are the topics in my conversation with Stephen Faust, pro grouse and woodcock guide, dog trainer and breeder, and avid hunter. We'll also cover a typical guide's day in the field, how we can be better guide clients, and dog training tips.  We'll track a woodcock's day - where it hangs, what it eats and even how professionals like Stephen tag chicks in the spring. We'll look at habitat and habits, and dog handling for these wily birds. Then, into the grouse woods for insights into some lesser-known prime food sources, cover types, and habitat needs from opening day to winter.  "Fix It" offers a useful web source for finding birds, and listeners (a lot of them) weigh in on "Do beeper collars scare birds?" You'll take something useful away from that discussion! And it's all brought to you by: HiVizSights.com, RuffLand Kennels, Mid Valley Clays and Shooting School, TrulockChokes, HiViz shooting systems, Pointer shotguns, Purina Pro Plan Sport and FindBirdHuntingSpots.com.

projectupland.com On The Go
Managing Grasslands for Sharp-tailed Grouse, Prairie Chickens, and Other Upland Birds

projectupland.com On The Go

Play Episode Listen Later Aug 25, 2025 17:25


In this article, biologists Kyle Hedges and Frank Loncarich discuss grassland management techniques that landowners and managers can utilize to help bolster upland bird populations on their properties.Check out Duck Camp's gear at duckcamp.com. Read more at projectupland.com.

Hannah and Erik Go Birding
Chasing Dusky Grouse in Washington

Hannah and Erik Go Birding

Play Episode Listen Later Aug 21, 2025 54:01


On our recent trip to Washington, we had two days to play with.  So we decided to go search out a lifer: Dusky Grouse.  Who knew we would find such a charming, interesting vacation destination, too!  Winthrop and the Methow Valley has a lot of great cascades birds to see and things to do.Adventure begins at: 12:15 Show notes Southeast Arizona Birding Festival Rio Grande Valley Birding Festival Spring ChirpeBird October Global Big DaySun Mountain LodgeWinthropeBird Trip Report Birds/Animals mentioned Kagu Dusky Grouse Lewis's Woodpecker Intro Bird Call: Vesper Sparrow (Recorded: June 2025, Washington)Outro Bird Call: Black-throated Gray Warbler (Recorded: June 2025, Washington) Support the showConnect with us at... IG: @Hannahgoesbirding and @ErikgoesbirdingFacebook: @HannahandErikGoBirdingEmail us at HannahandErikGoBirding@gmail.comWebsite: http://www.gobirdingpodcast.comVenmo: @hannahanderikgobirdingGet a discount at Buteo Books using code: BIRDNERDBOOKCLUB

Communism Exposed:East & West(PDF)
Day in Photos: 105-Year-Old Royal Marines Veteran, Heatwave in Europe, and Grouse Hunting Season

Communism Exposed:East & West(PDF)

Play Episode Listen Later Aug 13, 2025 88:03


ScotLand Matters: The Scottish Land and Estates Podcast
50. Beyond the Glorious Twelfth: Why Grouse Moors Matter in Scotland

ScotLand Matters: The Scottish Land and Estates Podcast

Play Episode Listen Later Aug 12, 2025 26:18


In this episode of ScotLand Matters podcast, Cameron is joined by SLE Director of Moorland, Ross Ewing, and Regional Coordinator for the Angus Glens Moorland Groups, Iona McGregor, to discuss the significance of the Glorious Twelfth, the start of the grouse shooting season in Scotland, and its multiple benefits to rural communities.The conversation covers the economic impact of grouse shooting, the social cohesion it fosters, the implications for food security, and the environmental management practices involved. Discussion also addresses the challenges posed by policy changes and the importance of inclusivity and education in the shooting sports community.As always, thank you for supporting the podcast and if you'd like to find out more check out the links below!Watch us on YouTube -⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/channel/UCZh6HQRipgDGqJDHxhSXVQg⁠⁠⁠⁠⁠⁠⁠Find out more about Scottish Land & Estates - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.scottishlandandestates.co.uk⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Find out about the Helping it Happen Awards - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.scottishlandandestates.co.uk/helping-it-happen

projectupland.com On The Go
Managing Grasslands for Sharp-tailed Grouse, Prairie Chickens, and Other Upland Birds

projectupland.com On The Go

Play Episode Listen Later Aug 3, 2025 15:14


In this article, biologists Kyle Hedges and Frank Loncarich discuss grassland management techniques landowners and managers can use to help bolster upland game bird populations on their properties.Read more at projectupland.com.

Project Upland Podcast
#326 | How Timeless Books Sparked a Passion for Grouse Hunting and Bird Dogs with Andy Wayment

Project Upland Podcast

Play Episode Listen Later Aug 1, 2025 68:55


In this episode of the Birdshot Podcast, host Nick Larson welcomes Andy Wayment, a passionate upland bird hunter, fly fisherman, and bibliophile, to discuss some of the best books in the world of upland hunting and fly fishing. Their conversation spans timeless authors like Burton Spiller and Tom Davis, plus a special look at books like Irish Red and Big Red. Whether you're a bird hunter, fly fisherman, or just a lover of outdoor literature, this episode is sure to inspire your next reading list. Andy Wayment is an avid upland bird hunter, fly fisherman, and self-proclaimed book nerd. With years of experience in bird hunting and a deep appreciation for literature, Andy has curated an extensive collection of hunting and fishing books. He is particularly passionate about sharing his knowledge of the classic authors and hidden gems in the genre. Andy has also authored his own books on Idaho upland hunting, contributing to the literary world of bird hunting. Expect to Learn The best books on upland bird hunting, including Irish Red and Big Red. Insights into the connections between fly fishing and bird hunting literature. Hidden gems in bird hunting books, including works by Burton Spiller and Tom Davis. Why fly fishing books also attract hunters and how the two pursuits often intersect in literature. The upcoming release of Andy's own book, Idaho Grouse Fever, and what readers can expect. Episode Breakdown with Timestamps [00:00:00] - Introduction to Andy Wayment and His Love for Books [00:03:52] - Andy's Story as a fly fisherman [00:10:23] - The Connection Between Fly Fishing and Upland Hunting books [00:15:59] - Authors and their Qualifications [00:25:05] - Irish Red and Big Red by Jim Kjelgaard [00:36:47] - Best Birds by Worth Mathewson [00:42:55] - Andy's New Book [00:57:40] - No. 1 Book - Drummer in the Woods [01:03:58] - Hour+ of Book Recommendations and Closing Thoughts. Follow Andy Wayment  Instagram: https://www.instagram.com/andywayment/  Website: https://uplandways.com/ ANDY'S TOP FIVE FAVORITES:  1.  Drummer in the Woods, Burton Spiller  2.  Partridge Shortenin', Gorham Cross (Grampa Grouse) 3.  My Friend the Patridge, S.T. Hammond  4.  That's Ruff, George King 5.  Grouse Feathers, Again, Burton Spiller Runner's Up:  6.  Upland Days, William G. Tapply 7.  Upland Autumn, William G. Tapply  8.  A Passion for Grouse, anthology edited by Tom Pero ANDY'S PICKS FOR FAVORITE UPLAND FICTION 1.  A Millionaire's Dream, Brett Wannacott 2.  A High Lonesome Call, Robert Holthowzer 3.  Jenny Willow, Mike Gaddis  4.  Irish Red, Jim Kjelgaard 5.  The Dumbell of Brookfield, John Tainter Foote BOOKS WITH SOME BLUE GROUSE HUNTING 1.  Fool Hen Blues, E. Donnell Thomas, Jr.  2.  A Hunter's Road and The Sporting Road, Jim Fergus 3.  Plateaus of Destiny, Mike Gould 4.  Kicking Up Trouble, John Holt 5.  Grouse of North America: A Cross-Continental Hunting Guide, Tom Huggler 6.  Winston, Ben O. Williams 7.  Idaho Upland Days, Andrew Marshall Wayment  8.  Hunting Upland Birds, Charley Waterman  Follow Host Nick LinkedIn: https://www.linkedin.com/in/xnicklarsonx/ Website: www.birdshotpodcast.com Instagram: https://www.instagram.com/birdshot.podcast/?hl=en Listening Links: Spotify: https://open.spotify.com/show/17EVUDJPwR2iJggzhLYil7 Apple Podcasts: https://podcasts.apple.com/us/podcast/birdshot-podcast/id1288308609 YouTube: http://www.youtube.com/@birdshotpodcast8302 SUPPORT | http://www.patreon.com/birdshot Use Promo Code | BSP20 to save 20% on https://www.onxmaps.com/hunt/app Use Promo Code | BS10 to save 10% on https://trulockchokes.com/ The Birdshot Podcast is Presented By: https://www.onxmaps.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Ahi Va
Ep. 52: Forest and Farm with Chrissy Streit

Ahi Va

Play Episode Listen Later Aug 1, 2025 79:57


When Chrissy Streit met and later married an avid hunter she made it clear that she was never, ever going to hunt. As a very conscientious eater of animal protein, her opinions about hunting shifted over time. When the young couple began a family and the thought of both the origin and the content of the food they would feed their children came into play, Chrissy really began to experience a change of perspective. Now, a very accomplished hunter, gardener, forager and cook, Chrissy shares her journey with others online through her various "Forest and Farm" platforms. In this episode, Jesse Deubel and Chrissy Streit talk about Chrissy's transition from being accepting of hunting to becoming a hunter herself. She shares heartfelt stories about the experiences she's had and how it has helped shape her view of life, death and food. From hunting grouse to elk and growing and harvesting species from rabbits to lettuce this episode covers four natural food procurement options that minimize our dependence on the local grocery market. Hunting, fishing, gardening and foraging are all covered in this entertaining and educational conversation. At the root of it all is a reminder about the importance of understanding that all living organisms on this planet are connected. The consequences of humans becoming increasingly distanced from the natural world are real. Being in nature helps our minds and our souls and the [real] food it provides feeds our bodies. Hopefully when you finish listening to this one you'll want to get outside, get your hands dirty and touch grass. Until then, enjoy the listen!  For more info:Forest and Farm FBForest and Farm InstagramNMWF Website

BASC
EP 62: The Grouse Season: How and Why We Work to Protect It

BASC

Play Episode Listen Later Aug 1, 2025 38:24


As the grouse season gets underway, we're diving into the people, politics and partnerships that keep the moorlands alive and thriving. In this episode, we explore why the grouse season matters, not just for sport but for conservation, community and the rural economy.We begin with BASC's head of uplands, Alex Farrell, who offers a clear-eyed view of the current political landscape and what lies ahead for upland shooting.Then we hear from Martin Quinn, an all-round field sportsman and seasoned picker-upper, as he walks us through a day on the moors, working his dogs and sharing the often-unseen camaraderie that powers every shoot day.To finish, we chat with conservationist and author Ian Coghill, who explains why he sees grouse moor management as one of the UK's real conservation success stories.

The Flush Podcast - Stories from the field
Grouse Hunting from Wisconsin to Montana

The Flush Podcast - Stories from the field

Play Episode Listen Later Jul 31, 2025 75:29


Mike Amman is a Wisconsin forester and the Vice President of the Wisconsin Sharp-Tailed Grouse Society. Mike & Travis celebrate Wisconsin's decision to re-open a sharp-tailed grouse hunting season, the mission at the Wisconsin sharp-tailed grouse society, reversing a habitat loss trend & bouncing back bird numbers, logging practices that create ruffed grouse habitat across the Great Lakes region, hunting sharp-tailed grouse on the prairie vs Midwest, moving to find the right hunting covers, mentally and physically preparing for opening day, shot size and chokes for grouse, putting on miles, and a whole lot more... @wisharptails   Presented by: Walton's (waltons.com/) OnX Maps (onxmaps.com/) Aluma Trailers (alumaklm.com) GAIM Hunting & Shooting Simulator (https://alnk.to/74wKReb) Compeer Home (compeerhome.com) Federal Premium Ammunition (federalpremium.com/) Hunt North Dakota (helloND.com/) Lucky Duck Premium Decoys (luckyduck.com/) & Samaritan Tire (samaritantire.com/)

The Badgerland Birding Podcast
Episode 82 - Talking Grouse and Birding Colorado with "The Grouse Guy" Jeremiah Psiropoulos

The Badgerland Birding Podcast

Play Episode Listen Later Jul 29, 2025 66:05


We talk with "The Grouse Guy", Jeremiah Psiropoulos about birding in Colorado, finding grouse, Colorado-style pizza, and more! Learn more about Jeremiah and his tours here: https://antigonewildlifetours.com/about

Project Upland Podcast
325 | Conserving Sharp-tailed Grouse Habitat in Wisconsin with Mike Amman

Project Upland Podcast

Play Episode Listen Later Jul 25, 2025 70:26


In this episode of The Birdshot Podcast, host Nick Larson is joined by Mike Amman, a County Forester in Wisconsin, to discuss the evolving landscapes of the state's upland habitats, with a particular focus on sharp-tailed grouse populations, habitat management, and conservation efforts. Mike shares his extensive experience working with county forests, overseeing land management practices that support both wildlife conservation and sustainable forestry. This episode also focuses on Mike's involvement and the exciting developments surrounding a limited hunting season for sharp-tailed grouse this fall. Mike Amman is a County Forester with over 22 years of experience working in forest management across Wisconsin's public and private lands. His expertise includes habitat restoration, wildlife management, and timber production, particularly within the context of county forest systems. Mike is also an active board member of the Wisconsin Sharp-tailed Grouse Society, a group dedicated to the conservation of sharp-tailed grouse populations and the unique barrens habitat of northwest Wisconsin. His commitment to preserving wildlife habitats while balancing sustainable forestry practices makes him an invaluable resource for land management in the region. Expect to Learn How Mike Amman manages and conserves county forest land in Wisconsin. The role of prescribed burns and mechanical treatments in restoring and maintaining sharp-tailed grouse habitat. Insights into the Wisconsin Sharp-tailed Grouse Society and its conservation efforts. The impact of forest fragmentation and land ownership changes on wildlife habitat. Why sharp-tailed grouse populations are thriving in some areas and the challenges involved in maintaining sustainable harvests for hunting seasons. Episode Breakdown with Timestamps [00:00:00] - Introduction [00:01:36] - A Day in the Life of a County Forester [00:05:46] - Major Differences in the Forest over time [00:18:00] - Fabric from Wood Fiber- Tencel [00:29:12] - 100+ Dancing Males on a Lek [00:38:11] - Give or Take Event [00:42:18] - Trips Out West Spur Mike's Interest in Sharp-tailed Grouse [00:48:46] - Considerations for Bird Dog Training [00:52:32] - Observation Tool For Sharp-tailed Grouse Sightings [00:56:56] - Learn More about the onX Hunt WI Game Bird Layer [00:03:18] - How to Connect with Mike Follow Guest Mike LinkedIn: https://www.linkedin.com/in/mike-amman-a361a62a/ Instagram: https://www.instagram.com/grouseweims/ Wisconsin Sharp-tailed Grouse Society: https://www.wisharptails.org/ Follow Host Nick LinkedIn: https://www.linkedin.com/in/xnicklarsonx/ Website: www.birdshotpodcast.com Instagram: https://www.instagram.com/birdshot.podcast/?hl=en Listening Links Spotify:https://open.spotify.com/show/17EVUDJPwR2iJggzhLYil7 Apple Podcasts:https://podcasts.apple.com/us/podcast/birdshot-podcast/id1288308609 YouTube:http://www.youtube.com/@birdshotpodcast8302 SUPPORT | http://www.patreon.com/birdshot Use Promo Code | BSP20 to save 20% on https://www.onxmaps.com/hunt/app Use Promo Code | BS10 to save 10% on https://trulockchokes.com/ The Birdshot Podcast is Presented By: https://www.onxmaps.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Outdoor News Radio
Episode 550 – 2025 grouse forecast, swimmer's itch and mergansers, ICAST recap, corner crossings

Outdoor News Radio

Play Episode Listen Later Jul 25, 2025 54:00


Top topics on Outdoor News Radio this week include a discussion with Managing Editor Rob Drieslein and Editor Tim Spielman on how swimmer's itch has created wrath toward common mergansers on some western Minnesota lakes. Then Charlotte Roy from the Minnesota DNR joins the program to break down the pretty good forecast for ruffed grouse […] The post Episode 550 – 2025 grouse forecast, swimmer's itch and mergansers, ICAST recap, corner crossings appeared first on Outdoor News.

Blood Origins
Episode 576 - Emily Graham and Ian Coghill || Fighting For The Moorlands, Part 1

Blood Origins

Play Episode Listen Later Jul 17, 2025 57:03


Grouse hunting on moors is likely one of the most heated hunting topics in the United Kingdom. Every year the industry comes under attack, and they have to stand up and fight to highlight the benefits that come from Grouse shooting on moors. In Part 1 of a series on "Fighting for the Moorlands", Robbie connects with two key individuals in the "Why Moorlands Matter" movement - Emily Graham and Ian Coghill (or commonly referred to as Coggers). If you have ever been interested in learning more about the fight against hunting in the United Kingdom, have heard about grouse shooting, or may have just heard about moors, this is the podcast to learn more about all of those subjects. Get to know the guest: https://www.scribehound.com/countryside/shooting-talk/s/shooting-debates/why-moorland-matters-my-interview-with-ian-coghill  Do you have questions we can answer? Send it via DM on IG or through email at info@bloodorigins.com Support our Conservation Club Members! Kayuga Broadheads: https://www.kayugabroadheads.com.au/  Lanthrop & Sons: https://lathropandsons.com/  Silent Pursuits: https://www.silentpursuits.com/  See more from Blood Origins: https://bit.ly/BloodOrigins_Subscribe Music: Migration by Ian Post (Winter Solstice), licensed through artlist.io This podcast is brought to you by Bushnell, who believes in providing the highest quality, most reliable & affordable outdoor products on the market. Your performance is their passion. https://www.bushnell.com  This podcast is also brought to you by Silencer Central, who believes in making buying a silencer simple and they handle the paperwork for you. Shop the largest silencer dealer in the world. Get started today! https://www.silencercentral.com  This podcast is brought to you by Safari Specialty Importers. Why do serious hunters use Safari Specialty Importers? Because getting your trophies home to you is all they do. Find our more at: https://safarispecialtyimporters.com  Learn more about your ad choices. Visit megaphone.fm/adchoices

ChrisCast
Flushing Grouse: The Machine Doesn't Care Who You Are

ChrisCast

Play Episode Listen Later Jul 10, 2025 24:27


A quiet bird can't be shot. A hidden fish can't be netted. A calm suspect cannot be tagged and fed into the system. This is older than any badge or slogan. Force survives by flushing what hides, tagging what flushes, and feeding on what shows itself. Everything else is theater.Any enforcement system needs visible prey. No visible crime or defiance means the budget shrinks and the dogs stay in the kennel. But a pond stocked with performative rage and careless bravado keeps the hunters fed. That's why the same body cam footage repeats the same lesson: the people who flap their wings keep the machine alive.The Matrix gave us the allegory. There, human bodies power the system. Here, it's your behavior. Every unnecessary word, every challenge posed like a dare, every “What did I do?” shouted when silence would have served you better — that's the charge that lights the trap. It doesn't matter if you're a billionaire's daughter in a Range Rover or a kid with no shoes — once you flap, you're visible.It always begins small. A broken taillight. An expired sticker. If you stay calm, polite, and small, you slip back into the brush. But if you puff up, if you make it about pride, the dogs come closer. The stop becomes a search. The search becomes resisting arrest. A fine that could have cost you an hour now stains your record for life.Many believe status will protect them. They believe the net knows bloodlines. But when the shark's eye goes blind, everything moving is meat. The dash cams prove it daily — a bored princess can be chewed up as easily as a trap baddie when they run their mouth.This cycle isn't accidental. Even the slogans that claim resistance — “F*** the police,” “Defy or you're a bootlicker” — keep the pond stocked. The system doesn't need you to win; it needs you to flap enough to be worth catching.The hardest truth is that once you're in the net, you're not solving a logic puzzle — you're rolling dice you can't control. Gun owners know this: never draw unless you must, because you can do everything right and still lose the roll. One angle of video, one DA looking to make a name, one jury with a grudge — that's all it takes.No trap is fair. It is not cowardice to stay small. It is not betrayal to comply. It's survival in a world run on force. Obscurity is the shield. Defiance is the bait. The machine does not care who you are. It cares only that you're big enough to catch.When the net tightens, stay small. When the dogs flush the bush, stay still. Pride feeds the trap. The bird that never flaps is the one that lives.

North Dakota Outdoors Podcast
Ep. 75 – Enjoy the Wave

North Dakota Outdoors Podcast

Play Episode Listen Later Jul 9, 2025 51:30


In this episode of NDO Podcast, we visit with Jesse Kolar, Department upland game management supervisor, and RJ Gross, Department upland game management biologist, about this year's high pheasant crowing counts, historical comparisons to the glory days and how deer don't have wings.

Continuum Audio
Radiographic Evaluation of Normal Pressure Hydrocephalus With Dr. Aaron Switzer

Continuum Audio

Play Episode Listen Later Jul 9, 2025 16:10


 Normal pressure hydrocephalus (NPH) is a clinical syndrome of gait abnormality, cognitive impairment, and urinary incontinence. Evaluation of CSF dynamics, patterns of fludeoxyglucose (FDG) uptake, and patterns of brain stiffness may aid in the evaluation of challenging cases that lack typical clinical and structural radiographic features. In this episode, Katie Grouse, MD, FAAN, speaks with Aaron Switzer, MD, MSc, author of the article “Radiographic Evaluation of Normal Pressure Hydrocephalus” in the Continuum® June 2025 Disorders of CSF Dynamics issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California San Francisco in San Francisco, California. Dr. Switzer is a clinical assistant professor of neurology in the department of clinical neurosciences at the University of Calgary in Calgary, Alberta, Canada. Additional Resources Read the article: Radiographic Evaluation of Normal Pressure Hydrocephalus Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Grouse: This is Dr Katie Grouse. Today I'm interviewing Dr Aaron Switzer about his article on radiographic evaluation of normal pressure hydrocephalus, which he wrote with Dr Patrice Cogswell. This article appears in the June 2025 Continuum issue on disorders of CSF dynamics. Welcome to the podcast, and please introduce yourself to our audience. Dr. Switzer: Thanks so much for having me, Katie. I'm a neurologist that's working up in Calgary, Alberta, Canada, and I have a special interest in normal pressure hydrocephalus. So, I'm very happy to be here today to talk about the radiographic evaluation of NPH. Dr Grouse: I'm so excited to have you here today. It was really wonderful to read your article. I learned a lot on a topic that is not something that I frequently evaluate in my clinic. So, it's really just a pleasure to have you here to talk about this topic. So, I'd love to start by asking, what is the key message that you hope for neurologists who read your article to take away from it? Dr. Switzer: The diagnosis of NPH can be very difficult, just given the clinical heterogeneity in terms of how people present and what their images look like. And so, I'd like readers to know that detailed review of the patient's imaging can be very helpful to identify those that will clinically improve with shunt surgery. Dr Grouse: There's another really great article in this edition of Continuum that does a really great job delving into the clinical history and exam findings of NPH. So, I don't want to get into that topic necessarily today. However, I'd love to hear how you approach a case of a hypothetical patient, say, where you're suspicious of NPH based on the history and exam. I'd love to talk over how you approach the imaging findings when you obtain an MRI of the brain, as well as any follow-up imaging or testing that you generally recommend. Dr. Switzer: So, I break my approach down into three parts. First, I want to try to identify ventriculomegaly and any signs that would support that, and specifically those that are found in NPH. Secondly, I want to look for any alternative pathology or evidence of alternative pathology to explain the patient's symptoms. And then also evaluate any contraindications for shunt surgery. For the first one, usually I start with measuring Evans index to make sure that it's elevated, but then I want to measure one of the other four measurements that are described in the article, such as posterior colossal angle zed-Evans index---or z-Evans index for the American listeners---to see if there's any other features that can support normal pressure hydrocephalus. It's very important to identify whether there are features of disproportionately enlarged subarachnoid space hydrocephalus, or DESH, which can help identify patients who may respond to shunt surgery. And then if it's really a cloudy clinical picture, it's complicated, it's difficult to know, I would usually go through the full evaluation of the iNPH radscale to calculate a score in order to determine the likelihood that this patient has NPH. So, the second part of my evaluation is to rule out evidence of any alternative pathology to suggest another cause for the patient's symptoms, such as neurodegeneration or cerebrovascular disease. And then the third part of my evaluation is to look for any potential contraindications for shunt surgery, the main one being cerebral microbleed count, as a very high count has been associated with the hemorrhagic complications following shunt surgery. Dr Grouse: You mentioned about your use of the various scales to calculate for NPH, and your article does a great job laying them out and where they can be helpful. Are there any of these scales that can be reasonably relied on to predict the presence of NPH and responsiveness to shunt placement? Dr. Switzer: I think the first thing to acknowledge is that predicting shunt response is still a big problem that is not fully solved in NPH. So, there is not one single imaging feature, or even combination of imaging features, that can reliably predict shunt response. But in my view and in my practice, it's identifying DESH, I think, is really important---so, the disproportionately enlarged subarachnoid space hydrocephalus---as well as measuring the posterior colossal angle. I find those two features to be the most specific. Dr Grouse: Now you mentioned the concept of the NPH subtypes, and while this may be something that many of our listeners are familiar with, I suspect that, like myself when I was reading this article, there are many who maybe have not been keeping up to date on these various subtypes. Could you briefly tell us more about these NPH subtypes? Dr. Switzer: Sure. The Japanese guidelines for NPH have subdivided NPH into three different main categories. So that would be idiopathic, delayed onset congenital, and secondary normal pressure hydrocephalus. And so, I think the first to talk about would be the secondary NPH. We're probably all more familiar with that. That's any sort of pathology that could lead to disruption in CSF dynamics. These are things like, you know, a slow-growing tumor that is obstructing CSF flow or a widespread meningeal process that's reducing absorption of CSF, for instance. So, identifying these can be important because it may offer an alternative treatment for what you're seeing in the patient. The second important one is delayed onset congenital. And when you see an image of one of these subtypes, it's going to be pretty different than the NPH because the ventricles are going to be much larger, the sulcal enfacement is going to be more diffuse. Clinically, you may see that the patients have a higher head circumference. So, the second subtype to know about would be the delayed onset congenital normal pressure hydrocephalus. And when you see an image of one of these subtypes, it's going to be a little different than the imaging of NPH because the ventricles are going to be much larger, the sulcal enfacement is going to be more diffuse. And there are two specific subtypes that I'd like you to know about. The first would be long-standing overt ventriculomegaly of adulthood, or LOVA. And the second would be panventriculomegaly with a wide foramen of magendie and large discernomagna, which is quite a mouthful, so we just call it PAVUM. The importance of identifying these subtypes is that they may be amenable to different types of treatment. For instance, LOVA can be associated with aqueductal stenosis. So, these patients can get better when you treat them with an endoscopic third ventriculostomy, and then you don't need to move ahead with a shunt surgery. And then finally with idiopathic, that's mainly what we're talking about in this article with all of the imaging features. I think the important part about this is that you can have the features of DESH, or you can not have the features of DESH. The way to really define that would be how the patient would respond to a large-volume tap or a lumbar drain in order to define whether they have this idiopathic NPH. Dr Grouse: That's really helpful. And for those of our listeners who are so inclined, there is a wonderful diagram that lays out all these subtypes that you can take a look at. I encourage you to familiarize yourself with these different subtypes. Now it was really interesting to read in your article about some of the older techniques that we used quite some time ago for diagnosing normal pressure hydrocephalus that thankfully we're no longer using, including isotope encephalography and radionuclide cisternography. It certainly made me grateful for how we've come in our diagnostic tools for NPH. What do you think the biggest breakthrough in diagnostic tools that are now clinically available are? Dr. Switzer: You know, definitely the advent of structural imaging was very important for the evaluation of NPH, and specifically the identification of disproportionately enlarged subarachnoid space hydrocephalus, or DESH, in the late nineties has been very helpful for increasing the specificity of diagnosis in NPH. But some of the newer technologies that have become available would be phase-contrast MRI to measure the CSF flow rate through the aqueduct has been very helpful, as well as high spatial resolution T2 imaging to actually image the ventricular system and look for any evidence of expansion of the ventricles or obstruction of CSF flow. Dr Grouse: Regarding the scales that you had referenced earlier, do you think that we can look forward to more of these scales being automatically calculated and reported by various software techniques and radiographic interpretation techniques that are available or going to be available? Dr. Switzer: Definitely yes. And some of these techniques are already in development and used in research settings, and most of them are directed towards automatically detecting the features of DESH. So, that's the high convexity tight sulci, the focally enlarged sulci, and the enlarged Sylvian fissures. And separating the CSF from the brain tissue can help you determine where CSF flow is abnormal throughout the brain and give you a more accurate picture of CSF dynamics. And this, of course, is all automated. So, I do think that's something to keep an eye out for in the future. Dr Grouse: I wanted to ask a little more about the CSF flow dynamics, which I think may be new to a lot of our listeners, or certainly something that we've only more recently become familiar with. Can you tell us more about these advances and how we can apply this information to our evaluations for NPH? Dr. Switzer: So currently, only the two-dimensional phase contrast MRI technique is available on a clinical basis in most centers. This will measure the actual flow rate through the cerebral aqueduct. And so, in NPH, this can be elevated. So that can be a good supporting marker for NPH. In the future, we can look forward to other techniques that will actually look at three-dimensional or volume changes over time and this could give us a more accurate picture of aberrations and CSF dynamics. Dr Grouse: Well, definitely something to look forward to. And on the topic of other sort of more cutting-edge or, I think, less commonly-used technologies, you also mentioned some other imaging modalities, including diffusion imaging, intrathecal gadolinium imaging, nuclear medicine studies, MR elastography, for example. Are any of these modalities particularly promising for NPH evaluations, in your opinion? Do you think any of these will become more popularly used? Dr. Switzer: Yes, I think that diffusion tract imaging and MR elastography are probably the ones to keep your eye out for. They're a little more widely applicable because you just need an MR scanner to acquire the images. It's not invasive like the other techniques mentioned. So, I think it's going to be a lot easier to implement into clinical practice on a wide scale. So, those would be the ones that I would look out for in the future. Dr Grouse: Well, that's really exciting to hear about some of these techniques that are coming that may help us even more with our evaluation. Now on that note, I want to talk a little bit more about how we approach the evaluation and, in your opinion, some of the biggest pitfalls in the evaluation of NPH that you've found in your career. Dr. Switzer: I think there are three of note that I'd like to mention. The first would be overinterpreting the Evans index. So, just because an image shows that there's an elevated Evans index does not necessarily mean that NPH is present. So that's where looking for other corroborating evidence and looking for the clinical features is really important in the evaluation. Second would be misidentifying the focally enlarged sulci as atrophy because when you're looking at a brain with these blebs of CSF space in different parts of the brain, you may want to associate that to neurodegeneration, but that's not necessarily the case. And there are ways to distinguish between the two, and I think that's another common pitfall. And then third would be in regards to the CSF flow rate through the aqueduct. And so, an elevated CSF flow is suggestive of NPH, but the absence of that does not necessarily rule NPH out. So that's another one to be mindful of. Dr Grouse: That's really helpful. And then on the flip side, any tips or tricks or clinical pearls you can share with us that you found to be really helpful for the evaluation of NPH? Dr. Switzer: One thing that I found really helpful is to look for previous imaging, to look if there were features of NPH at that time, and if so, have they evolved over time; because we know that in idiopathic normal pressure hydrocephalus, especially in the dash phenotype, the ventricles can become larger and the effacement of the sulci at the convexity can become more striking over time. And this could be a helpful tool to identify how long that's been there and if it fits with the clinical history. So that's something that I find very helpful. Dr Grouse: Absolutely. When I read that point in your article, I thought that was really helpful and, in fact, I'm guessing something that a lot of us probably aren't doing. And yet many of our patients for one reason or other, probably have had imaging five, ten years prior to their time of evaluation that could be really helpful to look back at to see that evolution. Dr. Switzer: Yes, absolutely. Dr Grouse: It's been such a pleasure to read your article and talk with you about this today. Certainly a very important and helpful topic for, I'm sure, many of our listeners. Dr. Switzer: Thank you so much for having me. Dr Grouse: Again, today I've been interviewing Dr Aaron Switzer about his article on radiographic evaluation of normal pressure hydrocephalus, which he wrote with Dr Patrice Cogswell. This article appears in the most recent issue of Continuum on disorders of CSF dynamics. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

WXPR Local Newscast
Food allergies, sharp-tailed grouse hunt, dam funding

WXPR Local Newscast

Play Episode Listen Later Jul 7, 2025 6:18


The Steamboat Comedy Podcast
Episode 142! Live from Dusky Grouse!

The Steamboat Comedy Podcast

Play Episode Listen Later Jun 29, 2025 50:53


In this LIVE episode of the Steamboat Comedy Podcast, Kyle Ruff and Matt Newland are joined by fellow comedians Mike Stanley and Aaron 'Mad Dog' Graham! The show takes place at Dusky Grouse Coffee shop here in Steamboat Springs, and we get a special coffee tasting with resident expert Collie! Topics also include Mike's commercial gig with Bell Tire, Aaron's bologna knees, and Sydney Sweeney at Jeff Bezos's $57,000,000 wedding

The Hunting Dog Podcast
Shooting grouse in my backyard

The Hunting Dog Podcast

Play Episode Listen Later Jun 28, 2025 81:46


Before we hit the microphone I asked Zach to walk my property to see what has happened in three the years since we logged our woods. I learned a lot! RGS/AWS is the shining star in the heavens we call home. Projects are popping up all over and the future is brite!! 

ThePrint
ThePrintPod: Hindutva grouse returns to haunt an MF Husain auction in Mumbai. Latest row & past controversies

ThePrint

Play Episode Listen Later Jun 11, 2025 7:22


Hindu Janajagruti Samiti has submitted a memorandum to Amit Shah, Devendra Fadnavis and CP Deven Bharti, warning of a public agitation if they refused to meet its demand.

Continuum Audio
Radiographic Evaluation of Spontaneous Intracranial Hypotension With Dr. Ajay Madhavan

Continuum Audio

Play Episode Listen Later Jun 11, 2025 20:00


Recently, sophisticated myelographic techniques to precisely subtype and localize CSF leaks have been developed and refined. These techniques improve the detection of various types of CSF leaks thereby enabling targeted therapies. In this episode, Katie Grouse, MD, FAAN, speaks with Ajay A. Madhavan, MD, author of the article “Radiographic Evaluation of Spontaneous Intracranial Hypotension” in the Continuum® June 2025 Disorders of CSF Dynamics issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California San Francisco in San Francisco, California. Dr. Madhavan is assistant professor of radiology at the Mayo Clinic in Rochester, Minnesota. Additional Resources Read the article: Radiographic Evaluation of Spontaneous Intracranial Hypotension Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Full episode transcript available here Dr Jones:  This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Grouse:  This is Dr Katie Grouse. Today I'm interviewing Dr Ajay Madhavan about his article on Radiographic Evaluation of Spontaneous Intracranial Hypotension, which he wrote with Dr Levi Chazen. This article appears in the June 2025 Continuum issue on disorders of CSF dynamics. Welcome to the podcast, and please introduce yourself to our audience. Dr Madhavan:  Hi, thanks a lot, Katie. Yeah, so I'm Ajay Madhaven. I'm a neuroradiologist at the Mayo Clinic in Rochester, Minnesota. I did all my training here, so, I've been here for a long time. And I have a lot of interest in spinal CSF leaks, and I do a lot of that work. And so I'm really excited to be talking about this article with you. Dr Grouse:  I'm really excited too. And in fact, it's such a pleasure to have you here talking today on this topic. I know a lot's changed in this field, and I'm sure many of our listeners are really interested in learning about the developments and imaging techniques to improve detection and treatment of CSF leaks, especially since maybe we've learned about this in training. I want to start by asking you what you think is the most important takeaway from your article. Dr Madhavan:  Yeah, that's a great question. I think---and you kind of already alluded to it---I think the main thing is, I hope people recognize that this field has really changed a lot in the last five to ten years, through a lot of multi-institutional collaboration and also collaboration between different specialties. We've learned a lot about different types of spinal CSF leaks, how we can recognize the disease, particularly the types of myelography that we need to be using to accurately localize and treat these leaks. Those are the things that have really evolved in the last five to ten years, and they've really helped us improve these patients' lives. Dr Grouse:  Can you remind us of the different common types of spinal leaks that can cause spontaneous intracranial hypotension? Dr Madhavan:  Yeah, so there are a number of different spinal CSF leaks, types, and I would say the three most common ones that really most people should try to be aware of and cognizant of are: first, ventral dural tears. So those are, like, just physical holes in the dura. And they're usually caused by little bone spurs that come from the vertebral columns. So, they're often patients who have some degenerative changes in their spine. And those are really very common. Another type of spinal CSF leak that we commonly see is a lateral dural tear. So that's like the same thing in a slightly different location. So instead of being in the front, it's off to the side of the dura laterally. And so, it's also just a hole in the dura. And then the third and most recently discovered type of spinal CSF leak is a CSF-venous fistula. So those are direct connections between the subarachnoid space and little paraspinal vein. And it took us a long time to even realize that this was a real pathology. But now that it's been recognized, we've found that this is actually quite common. So those three types of leaks are probably the three most common that we see. And there's certainly others out there, but I would say over 90% of them fall into one of those three categories. Dr Grouse:  That's a great review, thank you. Just as another quick review, as we talk more about this topic, can you remind us of some of the most common or typical brain imaging findings that you'll see in cases of spontaneous intracranial hypotension? Dr Madhavan:  Yeah, absolutely. So, when you do a brain MRI in a patient who has spontaneous intracranial hypotension, you will usually, though not always, see typical brain MRI abnormalities. And I kind of think of those as falling into three different categories. So, the first one I think of is dural enhancement or thickening. So that's enlargement or engorgement of the dura, the pachymeninges, and enhancement on postgadolinium imaging. So, that's kind of the first category. The second is that, when you lose spinal fluid volume, other things often expand to take up the space. So, for example, you can get distension or enlargement of the dural venous sinuses, and sometimes you can also get subdural food collections or hematomas. They can arise spontaneously. And I kind of think of those as, you know, you, you've lost the cerebrospinal fluid volume and something else is kind of filling up the space. And then the third category is called brain sagging. And that's a constellation of findings where the posterior fossa structures and the pituitary gland in the cell have become abnormal because you've lost the fluid that normally cushions those structures and causes them to float up. For example, the brain stem will sag down, the distance between the mammillary body and the ponds may become reduced. The suprasellar cistern space may be reduced such that the optic chiasm becomes very close to the pituitary gland, and the prepontine cistern may also become reduced in size. And there are various measurements that can be used to determine whether something is subtly abnormal. But just generally speaking, those are really the three categories of brain MRI abnormalities you'll see. Dr Grouse:  That was a great review. And of course, I think in many times when we are thinking about or suspecting this diagnosis, we may be lucky to find those imaging findings to reinforce a diagnosis. Because as it turns out, after reading your article, I was really surprised to find out that in as many as 19% of cases we actually see normal brain imaging, which really was a surprise to me, I have to say. And I think that this really encompasses why spontaneous intercranial hypotension is such a difficult diagnosis to make. I think a lot of us struggle with how far to take the workup when, you know, spontaneous intercranial hypotension is clinically suspected, but multiple imaging studies are normal. Do you have any guidance on how to approach these more difficult cases? Dr Madhavan:  So, that's a really good question. And you know, it's- as you can imagine, that's a topic that comes up in most meetings where people discuss this, and it's been a continued challenge. And so, like you said, about 19 or 20% of patients who have this disease can have a, a normal brain MRI. And we've tried to do some work to figure out why that is and how we can identify patients who still have the disease. And I can just provide, I guess, some tips that have helped me in my clinical practice. One thing is, if I ever see a patient with a normal brain MRI where this disease is clinically suspected---for example, maybe they have orthostatic headaches or other very typical symptoms and we don't know why, but their brain MRI is normal---the first thing I do is I try to look back at their old imaging. So many times, these patients who present to us at Mayo, who, when we do their MRI scan here, their brain MRI looks normal… if you really look back at imaging that they've had done elsewhere---maybe even two to three years prior---at the time their symptoms started, they actually had some abnormalities. So, I might see that a patient, two years ago, had dural enhancement that spontaneously resolved; but now they still have symptoms of SIH and they may still have a CSF leak that we can find and treat, but their brain MRI has, for whatever reason, normalized. So, I always start by looking back at old imaging, and I found that to be very helpful. The other thing is, if you see a patient with a normal brain MRI, it's also important to look at their spine MRI because that can provide clues that might suggest that they could still have a spinal CSF leak. And the two things I look for on the spine MRI: one, if there's any extradural CSF. So, spinal fluid outside of where it's supposed to be within the confines of the subarachnoid space. And you know, really, if you see extradural CSF, you know they probably have a spinal fluid leak somewhere. Even if their brain MRI is normal, that just gives you the information that there is a dural tear probably somewhere. And so, in those patients we'll definitely still proceed to myelography or other testing, even if they have a normal brain MRI. And then the last thing I look for is whether or not they have prominent meningeal diverticula. Patients with CSF venous fistulas almost always have one or more prominent diverticula on their spine along the nerve root sleeves. And that's probably because most of these fistulas come from nerve root sleeve diverticula. We don't completely understand the pathogenesis of CSF venous fistulas, but they're clearly associated with meningeal diverticula. So, if I see a patient who has a normal brain MRI, but I see on their spine MRI that they have many meningeal diverticula that are relatively prominent, that makes me more inclined to be a little bit more aggressive in doing myelography to find a CSF leak. And then I look at other demographic features, too. So, for example, elevated BMI and older age are associated with CSF venous fistulas. So, that can help you determine whether or not it's warranted to go on to more advanced imaging, too. So those are all just a variety of different things that we've used to help us. Dr Grouse:  Thank you for sharing that. I wanted to go on to say that, you know, reading your article, of course, as you mentioned, you alluded to the fact there's lots of new imaging modalities out there. It was very illuminating and just an excellent resource for the options that exist and when they're useful. You did a great job summarizing it. And I encourage our readers to check out your article, to refresh themselves, update themselves on what's happened in this space. And of course, we can't summarize them all today, but I was wondering if you could possibly walk us through a hypothetical case of a patient who comes in with a history very suspicious for SIH? How would you approach this patient? Say you have gotten imaging that suggested that there is a spinal fluid leak and now you have to figure out where it is. Dr Madhavan:  Yeah. So, you know, I think the most typical scenario it'll be a patient who has been seen by one of my excellent neurology colleagues and they've done a brain MRI and they've made the diagnosis through a combination of clinical information and brain MRI finding. And then the next thing we'll do always is, we'll obtain a spine MRI. So, I think of the purpose of the spine MRI as to determine what type of spinal fluid leak they have. On the spine MRI, if you see extradural CSF, those patients essentially always will have a dural tear. And it may be a ventral dural tear or a lateral dural tear. But if you see extradural CSF, that is pretty much what they have. And conversely, if you don't see extradural CSF---if you just see, for example, many meningeal diverticula, but you don't see anything else particularly abnormal---most of those patients have a CSF venous fistula, just common things being common. So I use the spine MRI to determine what type of leak they have. And then the next thing I think about is, okay, I'm going to do a myelogram on this patient. How do I want to position them? Because it turns out that positioning is probably the most important factor for finding these spinal fluid leaks. You have to have the patient positioned correctly to find the leak that you're trying to localize. And so, if I suspect they have a ventral dural tear, I will always position those patients prone for their myelogram. And I might do one of many different types of myelograms. And, you know, the article talks about things like digital subtraction myelography and dynamic CT myelography. And you can find any of these leaks with any of those techniques, but you just have to have the patient positioned correctly. So, if I think I have a ventral dural tear, I'll put them prone for the myelogram. If I think they have a lateral dural tear, I'll put them in the cubitus position for the myelogram. And also, if they- if I think they have a CSF-venous fistula, I'll also put them in the decubitus position. Obviously if you're putting them in the decubitus position, you have to decide whether it's going to be left or right side down. So that may require a two-day exam. Sometimes you don't have to; in many cases, we're able to just do everything in one day. But those are all the different factors I think about when I'm trying to determine how I'm going to work those patients up further. So, I really use the spine MRI chiefly to think about what type of leak they're going to have and how I'm going to plan the myelogram. Dr Grouse:  That's really great. And it's, I think, really nice to emphasize how much the positioning matters in all this, which I think is not something we've been classically taught as far as the diagnosis of spinal leaks. Another thing I'm really interested in your opinion on is, you talked a lot about how to optimize and what can make you successful at diagnosis. I'm curious what you think one of the easiest mistakes to make or, you know, that we should hopefully avoid when treating patients with this disease. Dr Madhavan:  Yeah. And I think, you know, one other thing that's been discussed a lot in this topic… you know, we've talked about the patients with a normal brain MRI. Another barrier or challenge particularly with CSF-venous fistulas is, sometimes they can be very subtle on imaging. So, it's not always you see it very definitive CSF-venous fistula where you can say, like, there's no question, that's a fistula. There are many times where we do a good-quality myelogram and we see something that looks, like, possible for a CSF venous fistula, or probable. If I had to put a number on it, maybe there's a 50 to 70% chance of real. So, in those cases, we end up wondering, like, should we treat this suspected leak? And I think one common mistake  or one thing that needs to be looked at further is, how do we handle these patients where we don't know whether the fistula is real or not? That's usually something where I will have a discussion with the patient, and I'm usually just very upfront with him about my interpretation of the imaging. I'll just tell them, we did a good-quality myelogram. You did a great job. We got good images. I don't see anything definitive, but I see this thing that I think has maybe a 60% chance of being real. And then I'll confer with one of my neurology colleagues and we'll decide whether it's worth treating that or not. And we'll just be very upfront with a patient about whether- about the likelihood of its success and what their long-term prognosis is. And oftentimes we let them make the decision. But I think that remains to be one of the big challenges is, how do we treat these patients who have suspected leaks that are not definitive on imaging. Dr Grouse:  That sounds absolutely like an important area where there can be problems, so I appreciate that insight. I'm interested what you think in your article would come as the biggest surprise to our listeners who may not have kept up as much with all of the changes that have happened in recent years? Dr Madhavan:  One of the things that was certainly, at least, a surprise to me as I was going through my training and learning about this topic is how diverse myelography has really become. You know, when I was a radiology resident, I learned about myelography as this thing that we've been doing for 30 to 40 years. And historically we've used myelograms just to look for degenerative changes: disc bulges, you know, disc herniations and things like that. Now that MRI is more prevalent, we don't use it as much, but it has turned out that it has a very big role in patients with spinal fluid leaks. Furthermore, something that I've learned is just how diverse these different types of myelograms have become. It used to kind of be just that a myelogram is a myelogram is a myelogram, but now we have different types of positioning, different types of equipment that we use. We vary the timing between contrast injection and imaging to optimize success for finding spinal fluid leaks. So, I think many times I talk to people who may not be as familiar with this field and they're surprised at just how diverse that has become and how sophisticated some of the various myelographic techniques have become and how much that really makes a difference in being able to accurately diagnose these patients. Dr Grouse:  Well, I can say it was a surprise to me. Even as someone who does treat quite a few patients with this condition, I was surprised to see the breadth of different options that have become available. And then kind of a follow-up to that, what do you think the current area of controversy is in this area of diagnosis and treatment? Dr Madhavan:  The biggest ones are ones you've sort of already alluded to. So, one big one is, how far do we go in patients who have a normal brain MRI who still have a clinical suspicion of the disease? And sometimes it's really hard, because sometimes you will find patients who clinically have a very strong case for having spontaneous intracranial hypotension. You look at them, they have very acute-onset orthostatic headaches. There's no better explanation for their symptoms that we know of. And it's hard to know what to do with those patients, because some of them want to continue to undergo diagnostic workup, but you can only do so many myelograms and you can only do so much with this diagnostic workup that requires some radiation dose before it becomes very challenging. That's a major point of just, I guess, ongoing research as to what can we do better for that subset of patients. Fortunately, it's not all of them, it's a subset of them, but I think we could help those patients better in the future as we learn more about the disease. So that's one. And the other one is treating these equivocal findings, like I discussed.  And where should our threshold be to treat a patient, and what type of treatment should we do in patients where we don't know whether a leak is real? Should we just do a very noninvasive- relatively noninvasive blood patch? Do we do an embolization where we're leaving a foreign body there? Is it worth sending those patients to surgery? Those are all unanswered questions and things that continue to spark ongoing debate. Dr Grouse:  Do you think that there's going to be any new big breakthroughs, or even, do you know of any big developments on the horizon that we should be keeping our eyes out for? Dr Madhavan:  You know, I think for me the biggest thing is, imaging is dramatically improving. We talked a little bit about photon counting detector CT in our article, and that's one of the newest and best techniques for imaging these patients because it has very, very high resolution, it has a lower radiation dose, it has allowed us to find leaks that we were not able to find before. And there are other high-resolution modalities that are emerging and becoming more accessible to things like cone beam CT which we do in addition to digital subtraction myelography. And on top of that, we've started to use AI-based tools to make images look a lot better. So, there are various AI algorithms that have come out that allow us to remove artifacts from imaging. They help us image patients with a bigger body habitus better without running into a lot of imaging artifacts. They help us reduce noise in imaging. They can just give us better-quality images and aid us in the diagnosis. For me as a radiologist, those are some of the most exciting things. We're finding less invasive ways with less radiation to better diagnose these patients with just better-quality imaging. Dr Grouse:  Well, that is definitely something to be excited about. So, I just want to thank you so much for talking with us today. It's been such an interesting, informative discussion and a real privilege to talk with you about this important topic. Dr Madhavan:  Yeah, thanks so much. I really appreciate the time to talk with you, and I look forward to seeing the article out there and hopefully getting some interesting questions. Dr Grouse:  Again, today I've been interviewing Dr Ajay Madhavan about his article on Radiographic Evaluation of Spontaneous Intracranial Hypotension, which he wrote with Dr Levi Chasen. This article appears in the most recent issue of Continuum on disorders of CSF dynamics. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Birds, Booze, and Buds Podcast
Mountain Grouse Master Class

Birds, Booze, and Buds Podcast

Play Episode Listen Later Jun 4, 2025 98:08


On this episode we continue our species specific series. Mountian Grouse in Montana is this weeks focus.  Primarily we talk about Blue Grouse but we do talk about both Spruce and Ruffed grouse also. George hasnt hunted them before but is very interested in them, so he asked Wess and Myself the questions that he was curious about and Wess and I did our best to answer.

Continuum Audio
BONUS EPISODE: Clinical Applications of Artificial Intelligence in Neurology Practice With Dr. Peter Hadar

Continuum Audio

Play Episode Listen Later May 24, 2025 23:45


As artificial intelligence (AI) tools become increasingly mainstream, they can potentially transform neurology clinical practice by improving patient care and reducing clinician workload. Critically evaluating these AI tools for clinical practice is important for successful implementation. In this episode, Katie Grouse, MD, FAAN speaks with Peter Hadar, MD, MS, coauthor of the article “Clinical Applications of Artificial Intelligence in Neurology Practice” in the Continuum® April 2025 Neuro-ophthalmology issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California San Francisco in San Francisco, California. Dr. Hadar is an instructor of neurology at Harvard Medical School and an attending physician at the Massachusetts General Hospital in Boston, Massachusetts. Additional Resources Read the article: Clinical Applications of Artificial Intelligence in Neurology Practice Subscribe to Continuum®: shop.lww.com/Continuum Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Guest: @PeterNHadar Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about subscribing to the journal, listening to verbatim recordings of the articles, and exclusive access to interviews not featured on the podcast. Dr Grouse: This is Dr Katie Grouse. Today I'm interviewing Dr Peter Hadar about his article on clinical applications of artificial intelligence in neurology practice, which he wrote with Dr Lydia Moura. This article appears in the April 2025 Continuum issue on neuro-ophthalmology. Welcome to the podcast, and please introduce yourself to our audience. Dr Hadar: Hi, thanks for having me on, Katie. My name is Dr Peter Hadar. I'm currently an instructor over at Mass General Hospital, Harvard Medical School, and I'm excited to talk more about AI and how it's going to change our world, hopefully for the better. Dr Grouse: We're so excited to have you. The application of AI in clinical practice is such an exciting and rapidly developing topic, and I'm so pleased to have you here to talk about your article, which I found to be absolutely fascinating. To start, I'd like to hear what you hope will be the key takeaway from your article with our listeners. Dr Hadar: Yeah, thank you. The main point of the article is that AI in medicine is a tool. It's a wonderful tool that we should be cautiously optimistic about. But the important thing is for doctors, providers to be advocates on their behalf and on behalf of their patients for the appropriate use of this tool, because there are promises and pitfalls just with any tool. And I think in the article we detail a couple ways that it can be used in diagnostics, in clinical documentation, in the workflow, all ways that can really help providers. But sometimes the devil is in the details. So, we get into that as well. Dr Grouse: How did you become interested in AI and its application, specifically in the practice of neurology? Dr Hadar: When I was a kid, as most neurologists are, I was- I nerded out on a lot of sci-fi books, and I was really into Isaac Asimov and some of his robotics, which kind of talks about the philosophy of AI and how AI will be integrated in the future. As I got into neurology, I started doing research neurology and a lot of folks, if you're familiar with AI and machine learning, statistics can overlap a lot with machine learning. So slowly but surely, I started using statistical methods, machine learning methods, in some of my neurology research and kind of what brought me to where I am today. Dr Grouse: And thinking about and talking about AI, could you briefly summarize a few important terms that we might be talking about, such as artificial intelligence, generative AI, machine learning, etcetera? Dr Hadar: It's a little difficult, because some of these terms are nebulous and some of these terms are used in the lay public differently than other folks would use it. But in general, artificial intelligence is kind of the ability of machines or computers to communicate independently. It's similar to as humans would do so. And there are kind of different levels of AI. There's this very hard AI where people are worried about with kind of terminator-full ability to replicate a human, effectively. And there are other forms of narrow AI, which are actually more of what we're talking about today, and where it's very kind of specific, task-based applications of machine learning in which even if it's very complex, the AI tools, the machine learning tools are able to give you a result. And just some other terms, I guess out there. You hear a lot about generative AI. There's a lot of these companies and different algorithms that incorporate generative AI, and that usually kind of creates something, kind of from scratch, based on a lot of data. So, it can create pictures, it can create new text if you just ask it. Other terms that can be used are natural language processing, which is a big part of some of the hospital records. When AI tools read hospital records and can summarize something, if it can translate things. So, it turns human speech into these results that you look for. And I guess other terms like large language models are something that also have come into prominence and they rely a lot on natural language processing, being able to understand human speech, interpret it and come up with the results that you want. Dr Grouse: Thank you, that's really helpful. Building on that, what are some of the current clinical applications of AI that we may already be using in our neurologic practice and may not even be aware that that's what that is? Dr Hadar: It depends on which medical record system you use, but a very common one are some of the clinical alerts that people might get, although some of them are pretty basic and they can say, you know, if the sodium is this level, you get an alert. But sometimes they do incorporate fancier machine learning tools to say, here's a red flag. You really should think about contacting the patient about this. And we can talk about it as well. It might encourage burnout with all the different flags. So, it's not a perfect tool. But these sorts of things, typically in the setting of alerts, are the most common use. Sorry, and another one is in folks who do stroke, there are a lot of stroke algorithms with imaging that can help detect where the strokes occur. And that's a heavy machine learning field of image processing, image analysis for rapid detection of stroke. Dr Grouse: That's really interesting. I think my understanding is that AI has been used specifically for radiology interpretation applications for some time now. Is that right? Dr Hadar: In some ways. Actually, my background is in neuroimaging analysis, and we've been doing a lot of it. I've been doing it for years. There's still a lot of room to go, but it's really getting there in some ways. My suspicion is that in the coming years, it's going to be similar to how anesthesiologists at one point were actively bagging people in the fifties, and then you develop machines that can kind of do it for you. At some point there's going to be a prelim radiology read that is not just done by the resident or fellow, but is done by the machine. And then another radiologist would double check it and make sure. And I think that's going to happen in our lifetime. Dr Grouse: Wow, that's absolutely fascinating. What are some potential applications of AI in neurologic practice that may be most high-yield to improve patient care, patient access, and even reduce physician burnout? Dr Hadar: These are separate sort of questions, but they're all sort of interlinked. I think one of the big aspects of patient care in the last few years, especially with the electronic medical record, is patients have become much more their own advocates and we focus a lot more on patient autonomy. So, they are reaching out to providers outside of appointments. This can kind of lead to physician burnout. You have to answer all these messages through the electronic medical record. And so having, effectively, digital twins of yourself, AI version of yourself, that can answer the questions for the patient on your off times is one of the things that can definitely help with patient care. In terms of access, I think another aspect is having integrated workflows. So, being able to schedule patients efficiently, effectively, where more difficult patients automatically get one-hour appointments, patients who have fewer medical difficulties might get shorter appointments. That's another big improvement. Then finally, in terms of physician burnout, having ambient intelligence where notes can be written on your behalf and you just need to double-check them after allows you to really have a much better relationship with the patients. You can actually talk with them one on one and just focus on kind of the holistic care of the patient. And I think that's- being less of a cog in the machine and focusing on your role as a healer would be actually very helpful with the implementation of some of these AI tools. Dr Grouse: You mentioned ambient technology and specifically ambient documentation. And certainly, this is an area that I feel a lot of excitement about from many physicians, a lot of anticipation to be able to have access to this technology. And you mentioned already some of the potential benefits. What are some of the potential… the big wins, but then also potential drawbacks of ambient documentation? Dr Hadar: Just to kind of summarize, the ambient intelligence idea is using kind of an environmental AI system that, without being very obtrusive, just is able to record, able to detect language and process it, usually into notes. So, effectively like an AI scribe that is not actually in the appointment. So, the clear one is that---and I've seen this as well in my practice---it's very difficult to really engage with the patient and truly listen to what they're saying and form that relationship when you're behind a computer and behind a desk. And having that one-on-one interaction where you just focus on the patient, learn everything, and basically someone else takes notes for you is a very helpful component of it. Some of the drawbacks, though, some of it has to do with the existing technology. It's still not at the stage where it can do everything. It can have errors in writing down the medication, writing down the exact doses. It can't really, at this point, detect some of the apprehensions and some of the nonverbal cues that patients and providers may kind of state. Then there's also the big one where a lot of these are still done by startups and other companies where privacy may be an issue, and a lot of patients may feel very uncomfortable with having ambient intelligence tools introduced into their clinical visit, having a machine basically come between the doctor and the patient. But I think that over time these apprehensions will lessen. A lot of the security will improve and be strengthened, and I think that it's going to be incorporated a lot more into clinical practice. Dr Grouse: Yeah, well, we'll all be really excited to see how that technology develops. It certainly seems like it has a lot of promise. You mentioned in your article a lot about how AI can be used to improve screening for patients for certain types of conditions, and that certainly seems like an obvious win. But as I was reading the article, I couldn't help but worry that, at least in the short term, these tools could translate into more work for busy neurologists and more demand for access, which is, you know, already, you know, big problems in our field. How can tools like these, such as, like, for instance, the AI fundoscopic screening for vascular cognitive risk factors help without adding to these existing burdens? Dr Hadar: It's a very good point. And I think it's one of the central points of why we wanted to write the article is that these AI in medicine, it's, it's a tool like any other. And just like when the electronic medical record came into being, a lot of folks thought that this was going to save a lot of time. And you know, some people would say that it actually worsened things in a way. And when you use these diagnostic screening tools, there is an improvement in efficiency, there is an improvement in patient care. But it's important that doctors, patients advocate for this to be value-based and not revenue-based, necessarily. And it doesn't mean that suddenly the appointments are shorter, that now physicians have to see twice as many patients and then patients just have less of a relationship with their provider. So, it's important to just be able to integrate these tools in an appropriate way in which the provider and the patient both benefit. Dr Grouse: You mentioned earlier about the digital twin. Certainly, in your article you mentioned, you know, that idea along with the idea of the potential of development of virtual chatbot visits or in-person visits with a robot neurologist. And I read all this with equal parts, I think excitement, but horror and and fear. Can you tell us more about what these concepts are, and how far are we from seeing technology like this in our clinics, and maybe even, what are the risks we need to be thinking about with these? Dr Hadar: Yeah. So, I mean, I definitely think that we will see implementation of some of these tools in our lifetime. I'm not sure if we're going to have a full walking, talking robot doing some of the clinical visits. But I do think that, especially as we start doing a lot more virtual visits, it is very easy to imagine that there will be some sort of video AI doctor that can serve as, effectively, a digital twin of me or someone else, that can see patients and diagnose them. The idea behind the digital twin is that it's kind of like an AI version of yourself. So, while you only see one patient, an AI twin can go and see two or three other patients. They could also, if the patients send you messages, can respond to those messages in a way that you would, based on your training and that sort of thing. So, it allows for the ability to be in multiple places at once. One of the risks of this is, I guess, overreliance on the technology, where if you just say, we're just going to have a chatbot do everything for us and then not look at the results, you really run the risk of the chatbot just recommending really bad things. And there is training to be had. Maybe in fifty years the chatbot will be at the same level as a physician, but there's still a lot of room for improvement. I personally, I think that my suspicion as to where things will go are for very simple visits in the future and in our lifetime. If someone is having a cold or something like that and it goes to their primary care physician, a chatbot or something like that may be of really beneficial use. And it'll help segment out the different groups of simple diagnosis, simple treatments can be seen by these robots, these AI, these machine learning tools; and some of the more complex ones, at least for the early implementation of this will be seen by more specialized providers like neurologists and subspecialist neurologists too. Dr Grouse: That certainly seems reasonable, and it does seem that the more simple algorithmic things are always where these technologies will start, but it'll be interesting to see where things can go with more complex areas. Now I wanted to switch gears a little bit in the article- and I thought this was really important because I see it as being certainly one of the bigger drawbacks of AI, is that despite the many benefits of artificial intelligence, AI can unfortunately perpetuate systemic bias. And I'm wondering if you could tell us a little bit more about how this happened? Dr Hadar: I know I'm beating a dead horse on this, but AI is a tool like any other. And the problem with it is that what you put in is very similar to what you get out. And there's this idea in computer science of “garbage in, garbage out”. If you include a lot of data that has a lot of systemic biases already in the data, you're going to get results that perpetuate these things. So, for instance, if in dermatologic practices, if you just had a data set that included people of one skin color or one race and you attempted to train a model that would be able to detect skin cancer lesions, that model may not be easily applicable to people of other races, other ethnicities, other skin colors. And that can be very damaging for care. And it can actually really, really hurt the treatments for a lot of the patients. So that is one of the, kind of, main components of the systemic biases in AI. The way we mitigate them is by being aware of it and actually implementing, I guess, really hard stops on a lot of these tools before they get into practice. Being sure, did your data set include this breakdown of sex and gender, of race and ethnicity? So that the stuff you have in the AI tool is not just a very narrow, focused application, but can be generalized to a large population, not just of one community, one ethnic group, racial group, one country, but can really be generalized throughout the world for many patients. Dr Grouse: The first step is being aware of it, and hopefully these models will be built thoughtfully to help mitigate this as much as possible. I wanted to ask as well, another concern about AI is the safety of private data. And I'm wondering, as we're starting to do things like use ambient documentation, AI scribe, and other types of technologies like this, what can we tell our patients who are concerned about the safety of their personal data collected via these programs, particularly when they're being stored or used with outside companies that aren't even in our own electronic medical records system? Dr Hadar: Yeah, it's a very good question, and I think it's one of the major limitations of the current implementation of AI into clinical practice, because we still don't really have great standards---medical standards, at least---for storing this data, how to analyze this data. And my suspicion is that at some point in the future, we're going to need to have a HIPAA compliance that's going to be updated for the 21st century, that will incorporate the appropriate use of these tools, the appropriate use of these data storage, of data storage beyond just PHI. Because there's a lot more that goes into it. I would say that the important thing for how to implement this, and for patients to be aware of, is being very clear and very open with informed consent. If you're using a company that isn't really transparent about their data security and their data sharing practices, that needs to be clearly stated to the patient. If their data is going to be shared with other people, reanalyzed in a different way, many patients will potentially consider not participating in an AI implementation in clinic. And I think the other key thing is that this should be, at least initially, an opt-in approach as opposed to an opt-out approach. So patients really have- can really decide and have an informed opinion about whether or not they want to participate in the AI implementation in medicine. Dr Grouse: Well, thank you so much for explaining that. And it does certainly sound like there's a lot of development that's going to happen in that space as we are learning more about this and the use of it becomes more prevalent. Now, I also wanted to ask, another good point that you made in your article---and I don't think comes up enough in this area, but likely will as we're using it more---AI has a cost, and some of that cost is just the high amount of data and computational processing needed to use it, as well as the effects on the environment from all this energy usage. Given this drawback of AI, how can we think about potential costs versus the benefits, the more widespread use of this technology? Or how should we be thinking about it? Dr Hadar: It's part of a balance of the costs and benefits, effectively, is that AI---and just to kind of name some of them, when you have these larger data centers that are storing all this data, it requires a lot of energy consumption. It requires actually a lot of water to cool these things because they get really hot. So, these are some of the key environmental factors. And at this point, it's not as extreme as it could be, but you can imagine, as the world transitions towards an AI future, these data centers will become huge, massive, require a lot of energy. And as long as we still use a lot of nonrenewable resources to power our world, our civilization, I think this is going to be very difficult. It's going to allow for more carbon in the atmosphere, potentially more climate change. So, being very clear about using sustainable practices for AI usage, whether it be having data centers specifically use renewable resources, have clear water management guidelines, that sort of thing will allow for AI to grow, but in a sustainable way that doesn't damage our planet. In terms of the financial costs… so, AI is not free. However, on a given computer, if you want to run some basic AI analysis, you can definitely do it on any laptop you have and sometimes even on your phone. But for some of these larger models, kind of the ones that we're talking about in the medical field, it really requires a lot of computational power. And this stuff can be very expensive and can get very expensive very quickly, as anyone who's used any of these web service providers can attest to. So, it's very important to be clear-eyed about problems with implementation because some of these costs can be very prohibitive. You can run thousands and you can quickly rack up a lot of money for some very basic analysis if you want to do it in a very rapid way, in a very effective way. Dr Grouse: That's a great overview. You know, something that I think we're all going to be having to think about a lot more as we're incorporating these technologies. So, important conversations I hope we're all having, and in our institutions as we're making these decisions. I wanted to ask, certainly, as some of our listeners who may be still in the training process are hearing you talk about this and are really excited about AI and implementation of technology in medicine, what would you recommend to people who want to pursue a career in this area as you have done? Dr Hadar: So, I think one of the important things for trainees to understand are, there are different ways that they can incorporate AI into their lives going forward as they become more seasoned doctors. There are clinical ways, there are research ways, there are educational ways. A lot of the research ways, I'm one of the researchers, you can definitely incorporate AI. You can learn online. You can learn through books about how to use machine learning tools to do your analysis, and it can be very helpful. But I think one of the things that is lacking is a clinician who can traverse both the AI and patient care fields and be able to introduce AI in a very effective way that really provides value to the patients and improves the care of patients. So that means if a hospital system that a trainee is eventually part of wants to implement ambient technology, it's important for physicians to understand the risks, the benefits, how they may need to adapt to this. And to really advocate and say, just because we have this ambient technology doesn't mean now we see fifty different patients, and then you're stuck with the same issue of a worse patient-provider relationship. One of the reasons I got into medicine was to have that patient-provider interaction to not only be kind of a cog in the hospital machine, but to really take on a role as a healer and a physician. And one of the benefits of these AI tools is that in putting the machine in medicine, you can also put the humanity back in medicine at times. And I think that's a key component that trainees need to take to heart. Dr Grouse: I really appreciate you going into that, and sounds like there's certainly need. Hoping some of our listeners today will consider careers in pursuing AI and other types of technologies in medicine. I really appreciate you coming to talk with us today. I think this is just such a fascinating topic and an area that everybody's really excited about, and hoping that we'll be seeing more of this in our lives and hopefully improving our clinical practice. Thank you so much for talking to us about your article on AI in clinical neurology. It was a fascinating topic and I learned a lot. Dr Hadar: Thank you very much. I really appreciate the conversation, and I hope that trainees, physicians, and others will gain a lot and really help our patients through this. Dr Grouse: So again, today I've been interviewing Dr Peter Hadar about his article on clinical applications of artificial intelligence in neurology practice, which he wrote with Dr Lydia Moura. This article appears in the most recent issue of Continuum on neuro-ophthalmology. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. Thank you for listening to Continuum Audio.

Project Upland Podcast
#318 | Grouse, Turkeys, Vintage Shotguns, and more with Lars Jacob

Project Upland Podcast

Play Episode Listen Later May 23, 2025 92:29


In this episode of the Birdshot podcast, host Nick Larson welcomes Lars Jacob, a seasoned hunter and shotgun fitting expert. They discuss hunting conditions in Vermont, the impacts of weather on grouse populations, and the challenges of grouse hunting. They also delve into the intricacies of shotgun fitting, the importance of practice for instinctive shooting, and the allure of vintage guns, particularly British and American models. The conversation rounds off with Lars sharing his experiences and insights into gun fitting, techniques, and some exciting upcoming events. 00:00 Introduction and Weather Update 03:01 Grouse Population and Habitat Challenges 04:15 Impact of West Nile Virus on Grouse 07:30 Cyclical Nature of Grouse Populations 08:20 Changes in Vermont's Habitat and Logging Practices 12:05 Public Land Grouse Hunting Tips 12:36 Grouse Diet and Seasonal Behavior 19:11 Historical Changes in Vermont's Landscape 22:19 Turkey Hunting Legacy and Techniques 41:25 Understanding Turkey Behavior and Hunting Techniques 42:53 The Evolution of Turkey Hunting Methods 43:33 The Importance of Patience in Turkey Hunting 45:04 Introduction to the Northeast Side by Side Classic Event 46:17 Highlights of the Northeast Side by Side Classic 47:25 The Art of Gun Fitting 51:41 The Process of Gun Fitting 01:01:52 Challenges and Techniques in Wing Shooting 01:08:47 The Value of Vintage Guns 01:19:06 Conclusion and Contact Information FOLLOW | @larsjacobwingshooting CONTACT | Lars Jacob at 802-289-2002 LISTEN | to Episode #167 and #277 with Lars Jacob SUPPORT | patreon.com/birdshot Follow us | @birdshot.podcast Use Promo Code | BSP20 to save 20% with onX Hunt Use Promo Code | BS10 to save 10% on Trulock Chokes The Birdshot Podcast is Presented By: onX Hunt, Final Rise and Upland Gun Company Learn more about your ad choices. Visit megaphone.fm/adchoices

Continuum Audio
Symptomatic Treatment of Neuro-ophthalmic Visual Disturbances With Dr. Sachin Kedar

Continuum Audio

Play Episode Listen Later May 21, 2025 22:46


Neuro-ophthalmic deficits significantly impair quality of life by limiting participation in employment, educational, and recreational activities. Low-vision occupational therapy can improve cognition and mental health by helping patients adjust to visual disturbances. In this episode, Katie Grouse, MD, FAAN, speaks with Sachin Kedar, MD, FAAN, author of the article “Symptomatic Treatment of Neuro-ophthalmic Visual Disturbances” in the Continuum® April 2025 Neuro-ophthalmology issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California San Francisco in San Francisco, California. Dr. Kedar is the Cyrus H Stoner professor of ophthalmology and a professor of neurology at Emory University School of Medicine in Atlanta, Georgia. Additional Resources Read the article: Symptomatic Treatment of Neuro-ophthalmic Visual Disturbances Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Guest: @AIIMS1992 Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Grouse: This is Dr Katie Grouse. Today I'm interviewing Dr Sachin Kedar about his article on symptomatic treatment of neuro-ophthalmic visual disturbances, which appears in the April 2025 Continuum issue on neuro-ophthalmology. Welcome to the podcast, and please introduce yourself to our audience. Dr Kedar: Thank you, Katie. This is Sachin Kedar. I'm a neuro-ophthalmologist at Emory University, and I've been doing this for more than fifteen years now. I trained in both neurology and ophthalmology, with a fellowship in neuro-ophthalmology in between. It's a pleasure to be here. Dr Grouse: Well, we are so happy to have you, and I'm just so excited to be discussing this article with you, which I found to be a real treasure trove of useful clinical information on a topic that many find isn't covered enough in their neurologic training. I strongly recommend all of our listeners who work with patients with visual disturbances to check this out. I wanted to start by asking you what you hope will be the main takeaway from this article for our listeners? Dr Kedar: The most important takeaway from this article is, just keep vision on your radar when you are evaluating your patients with neurological disorders. Have a list of a few symptoms, do a basic screening vision, and ask patients about how their vision is impacting the quality of life. Things like activities of daily living, hobbies, whether they can cook, dress, ambulate, drive, read, interact with others. It is very important for us to do so because vision can be impacted by a lot of neurological diseases. Dr Grouse: What in the article do you think would come as the biggest surprise to our listeners? Dr Kedar: The fact that impairment of vision can magnify and amplify neurological deficits in a lot of what we think of as core neurological disorders should come as a surprise to most of the audience. Dr Grouse: On that note, I think it's probably helpful if you could remind us about the types of visual disturbances we should be thinking about and screening for in our patients? Dr Kedar: Patients who have neurological diseases can have a whole host of visual deficits. The simplest ones are deficits of central vision. They can have problems with their visual field. They can have abnormalities of color vision or even contrast sensitivity. A lot of our patients also complain of light sensitivity, eyes feeling tired when they're doing their usual stuff. Some of our patients can have double vision, they can have shaky vision, which leads to their sense of imbalance and maybe a fall risk to them. Dr Grouse: It's really helpful to think about all the different aspects in which vision can be affected, not just sort of the classic loss of vision. Now, your article also serves as a really important reminder, which you alluded to earlier, about how impactful visual disturbances can be on daily activities. Could you elaborate a little further on this, and particularly the various domains that can be affected when there are visual disturbances present? Dr Kedar: So, when I look at how visual disturbances affect quality of life, I look at two broad categories. One is activities of basic daily living. These would be things like, are you able to cook? Are you able to ambulate not just in your home, but in your neighborhood? Are you able to drive to your doctor's appointment or to visit with your family? Are you able to dress yourself appropriately? Are you able to visualize the clothing and choose them appropriately? And then the second category is recreational activities. Are you able to read? Are you able to watch television? Are you able to visit the theatre? Are you able to travel? Are you able to participate in group activities, be it with your family or be it with your social group? It is very important for us to ask our patients if they have problems doing any of this because it really can adversely impact the quality of life. Dr Grouse: I think, certainly with all the things we try to get through talking with our patients, this may not be something that we do spend a lot of time on. So, I think it's it is a good reminder that when we can, being able to ask about these are going to be really important and help us hit on a lot of other things we may not even realize or know to ask about. Now, I was really struck when I was reading your article by the meta-analysis that you had quoted that had showed 47% higher risk of developing dementia among the visually impaired compared to those without visual impairments. Should we be doing more in-depth visual testing on all of our patients with cognitive symptoms? Dr Kedar: This is actually the most interesting part of this article, and kind of hones in on the importance of vision in neurological disorders. Now I want to clarify that patients with visual disorders, it's not a causative influence on dementia, but if you have a patient with an underlying cognitive disorder, any kind of visual disturbance will significantly make it worse. And this has been shown in several studies, both in the neurologic and in the ophthalmological literature. So, I quoted one of the big meta-analysis over there, but studies have clearly shown that if you have these patients and treat them for their visual deficits, their cognitive indices can actually significantly improve. To answer your question, I would say a neurologist should include basic vision screening as part of every single evaluation. Now, I know it's a hard thing in, you know, these days when we are literally running on the hamster wheel, but I can assure you that it won't take you more than 2 to 3 minutes of your time to do this basic screening; in fact, you can have one of your assistants included as part of the vital signs assessment. What are these basic screening tools? Measure the visual acuity for both near and distance. Check and see if their visual field's off with the confrontation. Look at their eye movements. Are they able to move their eyes in all directions? Are the eyes stable when they're trying to fixate on a particular point? I think if you can do these basic things, you will have achieved quite a bit. Dr Grouse: That's really helpful, and thanks for going through some of the standard, or really, you know, solid basic foundation of visual testing we should be thinking about doing. I wanted to move on to some more details about the visual disturbances. You made an excellent point that there are many types of primary ophthalmologic conditions that can cause visual disturbances that we should keep in mind. So maybe not things that we think about a lot on a day-to-day basis, but, you know, are still there and very common. What are some of the most common ones, and when should we be referring them to see an ophthalmologist? Dr Kedar: So, it depends on the age group of your patient population. Now, the majority of us are adult neurologists, and so the kinds of ophthalmic conditions that we see in this population is going to be different from the pediatric age group. So in the adult population, we might see patients with uncorrected refractive error, presbyopia, patients who have cataracts creep on them, they may have glaucoma, they may have macular degeneration, and these tend to have a slightly higher incidence in the older age group. Now for those of us who are taking care of the younger population, uncorrected refractive errors, strabismus and amblyopia tend to be fairly common causes of visual deprivation in this age group. What I would encourage all of our neurologists is, make sure that your patients get a basic eye examination at least once a year. Just like you want them to go to their primary care and get an annual maintenance visit, everybody should go to the ophthalmologist or the optometrist and get a basic examination. And, if you're resourceful enough, have your patients bring a copy of that assessment. Whether it is normal or there's some abnormality, it is going to help you in the management. Dr Grouse: Absolutely. I think that's a great piece of advice, to think of it almost, like, them seeing their primary care doctor, which of course we offer encourage our patients to do, thinking of this as another very important piece of standard primary care. If a patient comes to you reporting difficulty reading due to possible visual disturbances, I'm curious, can you walk us through how you would approach this evaluation? Dr Kedar: It is not a very common presenting complaint of our patients, even in the neuro-ophthalmology clinic. It's a very rare patient that I see who comes and says, I cannot read or, I have difficulty reading. Most of the patients will come saying, oh, I cannot see. And then you have to dig in to find out, what does that actually mean? What can you not see? Is it a problem in your driving? Is it a problem in your reading? Or is it a problem that occurs at all times? Now you asked me, how do you approach this evaluation? One of the things that all of us, whether we are neurologists, ophthalmologists, or neuro-ophthalmologists, forget to do is to actually have the patient read a paragraph, a sentence, when they are in clinic. And that will give you a lot of ideas about what might actually be going wrong with the patient. Now, as far as how do I approach this evaluation, I will do a basic screening examination to make sure that their visual acuity is good for both distance and near. A lot of us tend to do either distance or near and we will miss the other parameter. You want to do a basic confrontation visual field to make sure that they do not have any subtle deficits that's impacting their ability to read. Examine the eye movements, do a fundoscopic examination. Now, once you've done this basic screening, as a neurologist, you already have some idea of whether your patient has a lesion along the visual pathways. If you suspect that this is a problem with, say, the visual pathways, ask your ophthalmology colleague to do a formal visual field assessment, and that'll pick up subtle deficits of central visual field. And lastly, don't forget higher visual function testing or cortical visual function testing. So basically, you're looking for neglect, phenomenon, or simultanagnosia, all of which tends to have an impact on reading. So, in the manuscript I have a schema of how you can approach a patient with reading difficulties, and in that ischemia you will see categories of where things can go wrong during the process of reading. And if you can approach your patient systematically through one of those domains, there's a fairly good chance that you'll be able to pick up a problem. Dr Grouse: Going a little further on to when you do identify problems with loss of central or peripheral vision, what are some strategies for symptomatic management of these types of visual disturbances? Dr Kedar: As a neurologist, if you pick up a problem with the vision, you have to send this patient to an eye care provider. The vast majority of people who have visual disturbances, it's from an eye disease. You know, as I alluded to earlier, it can be something as simple as uncorrected refractive error, and that can be fixed easily. A lot of patients in our older age group will have dry eye syndrome, which means they are unable to adequately lubricate the surface of the eye, and as a result, it degrades the quality of their vision. So, they tend to get intermittent episodes of blurred vision, or they tend to get glare. They tend to get various forms of optical aberration. Patients can have cataracts, patients can have glaucoma or macular degeneration. And in all of those instances, the goal is to treat the underlying disease, optimize the vision, and then see what the residual deficit is. By and large, if a patient has a problem with the central vision, then magnification will help them for activities that they perform at near; say, reading. Now for patients with peripheral vision problem, it's a different entity altogether. Again, once you've identified what the underlying cause is, your first goal is to treat it. So, for example, if your patient has glaucoma, which is affecting peripheral vision, you're going to treat glaucoma to make sure that the visual field does not progress. Now a lot of what happens after that is rehabilitation, and that is always geared towards the specific activities that are affected. Is it reading? Is it ambulating? Is it watching television? Is it driving? And then you can advise as a neurologist, you can advise your occupational therapist or low vision specialist and say, hey, my patient is not able to do this particular activity. Can we help them? Dr Grouse: Moving on from that, I wanted to also hit on your approach when patients have disorders of ocular motility. What are some things you can do for symptomatic management of that? Dr Kedar: So, patients with ocular motility can have two separate symptoms. Two, you know, two disabling symptoms, as they would call it. One is double vision and the other is oscillopsia, or the feeling or the visualization of the environment moving in response to your eyes not being able to stay still. Typically, you would see this in nystagmus. Now, let's start with diplopia. Diplopia is a fairly common presenting complaint for neurologists, ophthalmologists, and the neuro-ophthalmologist. The first aspect in the management of diplopia is to differentiate between monocular diplopia and binocular diplopia. Now, monocular diplopia is when the double vision persists even after covering one eye. And that is never a neurological issue. It's almost always an ophthalmic problem, which means the patient will then have to be assessed by an eye care provider to identify what's causing it. And again, refractive error, cataracts, opacities, they can do it. Now, if the patient is able to see single vision by covering one eye at a time, that's binocular diplopia. Now, in patients with binocular diplopia in the very early stages of the disease, the standard treatment regimen is just monocular occlusion. Cover one eye, the diplopia goes away, and then give it time to improve on its own. So, this is what we would typically do in a patient with, say, acute sixth nerve palsy or fourth nerve palsy or third nerve palsy, maybe expect spontaneous improvement in a few months. Now if the double vision does not improve and persists long term, then the neuro-ophthalmologist or the ophthalmologist will monitor the amount of deviation to see if it fluctuates or if it stays the same. So, what are the treatment options that we have in a patient who absolutely refuses any intervention or is not a candidate for any intervention? Monocular occlusion still remains the viable option. Now, patients who have stable ocular deviation can benefit from using prisms in their glasses, or they can be sent to a surgeon to have a strabismus surgery that can realign their eyes. So, again, a broad answer, but there are options available that we can use. Dr Grouse: Thank you for that overview. I think that's just really helpful to keep in mind as we're working with these patients and thinking about what their options are. And then finally, I wanted to touch on patients with higher-order vision processing and attention difficulties. What are some strategies for them? Dr Kedar: These are frankly the most difficult patients that I get to manage in my clinic, simply because there is no effective therapies for managing them. In fact, I think neurologists are far better at this than ophthalmologists or even neuro-ophthalmologists. In patients with attentional disorders, everything boils down to the underlying cause, whether you can treat it or whether it is a slowly progressive, you know, condition, such as from neurodegenerative diseases. And that tailors our goals towards therapy. The primary goal is for safety. A lot of these patients who have visual disturbances from vision processing or attention, they are at accident and fall risk. They have problems with social interactions. And, importantly, there is a gap of understanding of what's going on, not just from their side but also from the family's side. So, I tend to approach these patients from a safety perspective and social interaction perspective. Now, I have a table listed in the manuscript which will go into details of what the specific things are. But in a nutshell, if your patient has neglect in a specific part of the visual field, they have accident risk on that side. Simple things like walking through a doorway, they can hurt their shoulders or their knees when they bang into the wall on that side because they are unable to judge what's on the other side. Another example would be a patient who has simultanagnosia or a downgaze policy, such as from progressive super nuclear policy. They are unable to look down fast enough, or they are simply unable to look down and appreciate things that are on the floor, and so they can trip and fall. Walking downstairs is also not a huge risk because they are unable to judge distances as they walk down. A lot of what we see in these patients are things that we have to advise occupational therapists and help them improve these safety parameters at home. Another thing that we often forget is patients can inadvertently cause a social incident when they tend to ignore people on their affected side. So, if there is a family gathering, they tend to consistently ignore a group of people who are sitting on the affected side as opposed to the other side. And I've had more than a few patients who've come and said that, I may have offended some of my friends and family. In those instances, it's always helpful when they are in clinic to demonstrate to the family how this can be awkward and how this can be mitigated. So, having everybody sit on one side is a useful strategy. Advise your family and friends before a gathering that, hey, this may happen. And it is not because it is deliberate, but it's because of the medical condition. And that goes a lot, you know, further in helping our patients come out of social isolation because they are also afraid of offending people, you know. And they can also participate socially, and it can overall improve their quality of life. Dr Grouse: That's a really helpful tip, and something I'll keep in mind with my patients with neglect and visual field cuts. Thank you so much for coming to talk with us today. Your article has been so helpful, and I urge everybody listening today to take a look. Dr Kedar: Thank you, Katie. It was wonderful talking to you. Dr Grouse: I've been interviewing Dr Sachin Kedar about his article on symptomatic treatment of neuro-ophthalmic visual disturbances, which appears in the most recent issue of Continuum on neuro-ophthalmology. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Upduck Podcast
Grouse, Grit, and Gordon Setters: Bird Camp in the U.P. with Jacob Perry from Superior Upland

Upduck Podcast

Play Episode Listen Later May 2, 2025 80:09


Tyler and Matt sit down with Jacob Perry of Superior Upland to talk life as a full-time upland guide in Michigan's Upper Peninsula. From building a guiding business with seven pointing dogs to why Gordon Setters stole his heart, Jake covers everything: bird habitat, client stories, gear advice, dog training philosophy, and the joy of sharing the woods with first-timers. Learn more about your ad choices. Visit megaphone.fm/adchoices

Show and Tell
That's Grouse!

Show and Tell

Play Episode Listen Later Apr 23, 2025 20:47 Transcription Available


This week, we kick off with a bit of music, a bit of Britney and Biebs, and the fashion comeback NOBODY wants. Mel’s torn trying to protect her daughter from dickheads in cars, and we share the stuff we’ve had piffed at us from them. One of us also thinks they’ve come up with the best new slogan for Vic numbers plates, and the other is not convinced. Enjoy! Fancy supporting us on Patreon? Find out more here. Follow us and get in touch on Instagram here. Follow us on Facebook here.See omnystudio.com/listener for privacy information.

Project Upland Podcast
#314 | Tracking the Dusky Grouse: A Journey Through Seasons and Space with Logan Clark

Project Upland Podcast

Play Episode Listen Later Apr 18, 2025 88:38


In this episode of The Birdshot Podcast, host Nick Larson talks with Logan Clark, a graduate researcher, about his extensive study on dusky grouse migrations and behavior. They discuss the challenges and innovations in monitoring wildlife, including the use of autonomous recording units (ARUs) and GPS tracking. Logan shares insights from his fieldwork, the modeling techniques applied for abundance estimation, and the future directions for dusky grouse research. 02:08 Pheasant Fest Experience 02:45 Poster Session and Networking 09:02 Research and Monitoring Techniques 37:40 Microphone vs. Human Detection 39:26 Challenges in Grouse Detection 40:07 Occupancy and Abundance Estimates 42:33 Machine Learning in Bird Detection 44:44 Developing Detection Models 52:50 Unexpected Discoveries 55:47 GPS Tracking and Grouse Movements 01:03:44 Future Research Directions 01:12:12 Career Aspirations and Challenges SUPPORT | patreon.com/birdshot Follow us | @birdshot.podcast Use Promo Code | BSP20 to save 20% with onX Hunt Use Promo Code | BS10 to save 10% on Trulock Chokes The Birdshot Podcast is Presented By: onX Hunt, Final Rise and Upland Gun Company Learn more about your ad choices. Visit megaphone.fm/adchoices

Fluent Fiction - Dutch
Mystery Unveiled: The Return of the Rare Black Grouse

Fluent Fiction - Dutch

Play Episode Listen Later Apr 2, 2025 16:23


Fluent Fiction - Dutch: Mystery Unveiled: The Return of the Rare Black Grouse Find the full episode transcript, vocabulary words, and more:fluentfiction.com/nl/episode/2025-04-02-22-34-01-nl Story Transcript:Nl: In het hart van de Nederlandse platteland, te midden van kleurrijke velden tulpen en molens, speelt zich een vreemd verhaal af.En: In the heart of the Nederlandse countryside, amidst colorful fields of tulips and windmills, a strange story unfolds.Nl: Elke avond, bij zonsondergang, verschijnt er een eigenaardige schaduw langs de rand van het tulpenveld.En: Every evening at sunset, an unusual shadow appears along the edge of the tulip field.Nl: De dorpsbewoners fluisteren erover, verbaasd en nieuwsgierig.En: The villagers whisper about it, both amazed and curious.Nl: Maar niemand durft dichterbij te komen.En: But no one dares to come closer.Nl: Bram, een nuchtere boer en kind van het platteland, hoort de verhalen.En: Bram, a down-to-earth farmer and child of the countryside, hears the stories.Nl: Hij gelooft niet in bijgeloof, maar iets in dit mysterie prikkelt zijn belangstelling.En: He does not believe in superstition, but something about this mystery piques his interest.Nl: Hij wil weten wat er aan de hand is.En: He wants to know what is going on.Nl: "Het is vast iets gewoons," denkt hij bij zichzelf.En: "It's probably something ordinary," he thinks to himself.Nl: Maar zijn nieuwsgierigheid wint het, en hij besluit de schaduw nader te onderzoeken.En: But his curiosity gets the better of him, and he decides to investigate the shadow further.Nl: Sanne daarentegen is een slimme botanist uit Amsterdam.En: Sanne, on the other hand, is a clever botanist from Amsterdam.Nl: Ze bezoekt het dorp om de schoonheid van de bloeiende tulpen te bestuderen.En: She visits the village to study the beauty of the blooming tulips.Nl: Maar de verhalen over de schaduw trekken ook haar aandacht.En: But the stories about the shadow also capture her attention.Nl: Sanne ziet het als een kans om iets nieuws te ontdekken en zoekt naar wetenschappelijk bewijs.En: Sanne sees it as an opportunity to discover something new and seeks scientific evidence.Nl: Bram en Sanne besluiten samen te werken, ondanks hun verschillende benaderingen.En: Bram and Sanne decide to work together, despite their different approaches.Nl: Bram is op zoek naar eenvoudige verklaringen.En: Bram is searching for simple explanations.Nl: Misschien een kapotte windmolen of een oude boom, denkt hij.En: Maybe a broken windmill or an old tree, he thinks.Nl: Sanne heeft haar gereedschap bij zich en meet veranderingen in de omgeving.En: Sanne has her tools with her and measures changes in the environment.Nl: Ze zijn het niet altijd eens, maar ze zijn vastbesloten de waarheid te vinden.En: They do not always agree, but they are determined to find the truth.Nl: Op een avond gaat Bram naar het veld.En: One evening, Bram goes to the field.Nl: Sanne volgt met haar apparaten.En: Sanne follows with her equipment.Nl: De lucht kleurt roze en oranje terwijl de zon zakt achter de horizon.En: The sky turns pink and orange as the sun sets behind the horizon.Nl: De schaduw verschijnt, groter en scherper dan ooit.En: The shadow appears, larger and sharper than ever.Nl: Het heeft de vorm van een vogel, maar niet zomaar een vogel.En: It has the shape of a bird, but not just any bird.Nl: Bram herkent de contouren, iets wat hij nooit had gedacht opnieuw te zien.En: Bram recognizes the contours, something he never thought he would see again.Nl: "Een korhoen," mompelt hij verbaasd.En: "A black grouse," he murmurs, astonished.Nl: Een zeldzame vogel die hier al jaren niet is gezien.En: A rare bird that has not been seen here for years.Nl: Sanne kijkt op en glimlacht.En: Sanne looks up and smiles.Nl: "We moeten het vastleggen!" Samen zetten ze hun onderzoek voort.En: "We must document it!" Together, they continue their research.Nl: Bram's kennis van de omgeving en Sanne's wetenschap komen samen.En: Bram's knowledge of the environment and Sanne's science come together.Nl: Ze maken foto's, notities, en meten alles wat ze kunnen.En: They take photos, make notes, and measure everything they can.Nl: Uiteindelijk, met bewijs in handen, informeren Bram en Sanne de lokale gemeenschap.En: Eventually, with evidence in hand, Bram and Sanne inform the local community.Nl: De mensen zijn opgetogen, de vogels zijn weer terug.En: The people are thrilled; the birds have returned.Nl: Bram leert om de mysteries van het leven te omarmen en Sanne ziet de waarde in van volkswijsheid.En: Bram learns to embrace the mysteries of life, and Sanne sees the value in folk wisdom.Nl: Ze beseffen dat ze een bijzonder moment hebben gedeeld. Een moment waar wetenschap en intuïtie elkaar ontmoetten, in de volle pracht van de Nederlandse lente.En: They realize they have shared a special moment—a moment where science and intuition met, in the full splendor of the Nederlandse spring.Nl: Zo sluiten ze hun avontuur af, met een hernieuwd respect voor zowel het onbekende als het vertrouwde.En: And so they conclude their adventure, with a renewed respect for both the unknown and the familiar.Nl: En elk jaar met Pasen kijken ze samen naar de velden, hopend op nog een glimp van de zeldzame korhoen, daar waar tulpen en verhalen bloeien.En: And every year at Easter, they watch the fields together, hoping for another glimpse of the rare black grouse, where tulips and stories bloom. Vocabulary Words:heart: hartamidst: te midden vancountryside: plattelandunusual: eigenaardigewhisper: fluisterenamazed: verbaasdcurious: nieuwsgierigdare: durftsuperstition: bijgeloofmystery: mysteriepique: prikkeltbotanist: botanistblooming: bloeiendeapproaches: benaderingendetermined: vastbeslotenhorizon: horizoncontours: contourenastonished: verbaasdgrouse: korhoenmurmurs: mompeltdocument: vastleggenenvironment: omgevingnote: notitiesthrilled: opgetogenembrace: omarmenwisdom: wijsheidintuition: intuïtiesplendor: prachtrenewed: hernieuwdglimpse: glimp

Harvesting Nature’s Wild Fish and Game Podcast
Episode 229: Bird Dogs, Big Bucks & Classic Perspectives with Project Upland's AJ DeRosa

Harvesting Nature’s Wild Fish and Game Podcast

Play Episode Listen Later Apr 1, 2025 93:40


Summary: In this episode, Justin Townsend and Adam Berkelmans discuss the evolving landscape of hunting in North America, focusing on the rise of food-focused hunters and urban deer hunting. They are joined by AJ DeRosa, who shares his insights on urban deer hunting, the importance of food in hunting culture, and the unique culinary experiences that come with wild game. The conversation explores the challenges and opportunities in modern hunting, conservation policies, and the stories that connect hunters and non-hunters alike. In this conversation, the speakers delve into various topics related to hunting, cooking, and conservation. They discuss the value of bear meat and fat, innovative cooking techniques using indigenous ingredients, and the underappreciated culinary potential of octopus. The conversation transitions into the origins and growth of Project Upland, emphasizing its authenticity and commitment to ethical hunting practices. The speakers also address the challenges facing hunting and conservation today, including the need for a more responsible approach to wildlife management and the importance of acknowledging the impact of lead in hunting. In this conversation, AJ discusses the evolving landscape of hunting, emphasizing the need for the community to embrace scientific truths and adapt to changing practices. He highlights the curiosity of younger hunters, the challenges of recruitment through the R3 program, and the integral role of food in hunting culture. AJ also delves into the political aspects of conservation, arguing that the narrative surrounding hunting has been skewed by partisan politics. He advocates for diplomacy and collaboration among hunters and conservationists to ensure the future of hunting rights and wildlife management. - Leave a Review of the Podcast - Buy our Wild Fish and Game Spices The Art of Venison Sausage Making Guest: AJ DeRosa Instagram Project Upland Instagram Project Upland Website Takeaways: Wild food is reshaping the way we think about hunting. Grouse hunting offers a unique culinary experience compared to big game hunting. Learning to handle wild game properly is essential for quality cooking. Diversity in wild game offers a rich culinary experience. Bear fat is highly valued for its culinary uses. Innovative cooking can elevate traditional ingredients. Octopus is an underappreciated delicacy that deserves more attention. Project Upland originated from a desire to spend more time hunting. Younger hunters are more curious and engaged with ecological issues. The narrative around hunting needs to be reframed. Community engagement is crucial for the future of hunting. Chapters: 00:00 Introduction to Wild Food and Hunting Culture 05:31 AJ DeRosa: Background and Urban Deer Hunting 09:31 The Evolution of Hunting Techniques 22:11 The Role of Food in Hunting 28:43 Culinary Experiences with Wild Game 29:10 The Value of Bear Meat and Fat 31:05 Innovative Cooking with Indigenous Ingredients 33:05 Exploring the Culinary Potential of Octopus 33:59 The Birth of Project Upland 38:54 The Authenticity of Project Upland 44:59 The Ethics of Hunting and Conservation 51:59 The Future of Hunting and Conservation Challenges 55:32 Embracing Change in Hunting Practices 58:11 The New Generation of Hunters 01:00:19 R3 Recruitment and Its Challenges 01:04:26 The Role of Food in Hunting Culture 01:07:03 Politics, Conservation, and Public Perception 01:12:39 The Class War in Hunting Rights 01:15:45 Building Bridges: Diplomacy in Conservation 01:20:34 The Future of Hunting and Food Culture Keywords: Wild food, hunting culture, urban deer hunting, conservation policy, food-focused hunters, hunting techniques, culinary experiences, wildlife, food culture, hunting, conservation, food culture, recruitment, public perception, politics, wildlife management, new generation hunters, R3 program, community engagement Learn more about your ad choices. Visit megaphone.fm/adchoices

The Natural History Cupboard Podcast

This week we head to the highlands to meet the capercaillie, a glorious grouse in need of help. In the news, we look at how all areas of modern science are contributing to a wider understanding of how dinosaurs lived. All this and more. The cupboard is open, come on in!

Bird Camp
Aspen Thicket Grouse Dogs sponsor segment

Bird Camp

Play Episode Listen Later Mar 26, 2025 43:48


Dennis and I catch up on some of the events and offerings at Aspen Thicket. We also go over a number of events hosted by Uncle Grouse this coming off season for the newcomer and experienced hunter alike.

Gun Talk
Family Gun Stories Continue; Hunting Grouse and Quail; Expired Pepper Spray: 03.23.25 After Show

Gun Talk

Play Episode Listen Later Mar 23, 2025 22:18


In This Hour:--  Family stories continue around a Montgomery Ward pump action 22.--  Hunting grouse and quail --  Make sure you check the expiration date on your pepper sprayGun Talk 03.23.25 After Show

Continuum Audio
EEG in Epilepsy With Dr. Daniel Weber

Continuum Audio

Play Episode Listen Later Feb 12, 2025 18:24


EEG is the single most useful ancillary test to support the clinical diagnosis of epilepsy, but if used incorrectly it can lead to misdiagnosis and long-term mental and physical health sequelae. Its application requires proper understanding of its limitations and variability of testing results. In this episode, Katie Grouse, MD, FAAN, speaks with Daniel Weber, DO, author of the article “EEG in Epilepsy,” in the Continuum® February 2025 Epilepsy issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California San Francisco in San Francisco, California. Dr. Weber is the director of adult epilepsy and vice chair of clinical affairs at the St. Louis University in St. Louis, Missouri. Additional Resources Read the article: EEG in Epilepsy Subscribe to Continuum: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Guest: @drdanielweber Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum, the premier topic-based neurology clinical review and CME journal from the American Academy of Neurology. Thank you for joining us on Continuum Audio, which features conversations with Continuum's guest editors and authors who are the leading experts in their fields. Subscribers to the Continuum journal can read the full article or listen to verbatim recordings of the article and have access to exclusive interviews not featured on the podcast. Please visit the link in the episode notes for more information on the article, subscribing to the journal, and how to get CME. Dr Grouse: This is Dr Katie Grouse. Today, I'm interviewing Dr Daniel Weber about his article on EEG and epilepsy, which appears in the February 2025 Continuum issue on epilepsy. Welcome to the podcast and please introduce yourself to our audience. Dr Weber: Hi, thanks for having me. My name is Dan Weber and I'm an epileptologist at Saint Louis University. I direct the adult epilepsy program here and also serve as the vice chair for Clinical Affairs. Been my pleasure to work on this article. Dr Grouse: I'm so happy to have you today. I read your article. I found it to be incredibly useful as someone who often orders EEG in the general neurology clinic. So, I wanted to start with asking, what is the most clinically relevant message or takeaway from your article that you'd really like neurologists to know?  Dr Weber: Yes, when I was asked to write this article, I looked back at the previous Continuum on epilepsy and just the general literature. And there's a lot of good articles and books out there on EEG and epilepsy and sort of giving you a primer on what you might see and how to interpret it. So, we wanted to try to go a slightly different direction. This article gives you some of that gives you the background of EEG and some of the basic things that you may see, but the real thrust of it is more about the limitations of EEG in the clinical picture of epilepsy and common things you might avoid. There are some things that we get hammered into our brains in training that aren't always true and there's plenty of examples in the literature to review, and this article sort of tries to encapsulate as many of those as possible in a digestible format. The main takeaway would be that EEG is an extremely helpful tool in the diagnosis of epilepsy, is the best tool we have to help supplement your clinical acumen. But it does not make the diagnosis of epilepsy. And there are certain circumstances when it may not be as helpful as you may have been led to believe in residency. Dr Grouse: Maybe not the most comforting of messages, but certainly an important one, very important to learn more about this. So, we appreciate that. Can you tell us your decision-making process when deciding whether to order a routine EEG, an extended EEG, prolonged ambulatory EEG, or inpatient video EEG? Dr Weber: Sure. So, it's a multi-part question because each one, I think, has a different clinical scenario. In the current state, our best data for estimating risk of recurrence after an initial seizure comes with routine EEG abnormalities. So, often I will order routine EEGs in those scenarios. So new patient presentation, new patients coming in with an initial seizure who want to know what's their risk of recurrence. So, risk stratification, I use a lot of routine EEG for, often sleep deprived if possible to increase the sensitivity. If you'd like, the extended EEG does offer higher sensitivity, or you can repeat the routine EEG if the first routine EEG is nonconclusive. For generally extended EEGs, I tend to order them in my practice if patients have come to see me with a suspected diagnosis of epilepsy but haven't yet had any electrographic confirmation. Maybe they've already had routine EEGs done in the past, so we'll try to obtain just a little more data. The longer-term EEGs I tend to use in different clinical scenarios, in patients usually who already have established diagnosis or people who have become refractory and we haven't yet confirmed their diagnosis. I tend to do inpatient EEGs in those situations. Ambulatory EEGs I do more when there are certain characteristics of the patient or the patient 's presentation that may not fit well on the inpatient side. Patients who are reliant on substances who can't use while they're inpatient and may have withdrawal effects complicating the stay. Or people who have a strong activation component to their epilepsy where activity really draws it out, certain activities that they do at home that they might not do during the inpatient stay. Those are the sorts of people I'll do ambulatory EEGs on. There are a couple other scenarios as well that come up less commonly, but everything has its own little niche. Dr Grouse: That's a really helpful review as we sort of think about which way we want to go as we're working up our patients in the inventory setting. Can you tell me a little more about the difference between sensitivity of, for instance, doing maybe two routine EEGS versus prolonged ambulatory EEG? Dr Weber: Generally speaking, the longer you're recording someone's brain waves, the higher the sensitivity is going to be. So routine EEG is twenty to forty minutes at most places. One of those gives you a certain sensitivity. More of them will give you more sensitivity. And there was a recent study highlighted in the article that compared routine EEGs to initial multi-day ambulatory EEG, and the ambulatory EEG obviously, as would be expected, has a higher sensitivity than either of the routines. So, there may be some cases with that initial evaluation where an ambulatory EEG may be held and we get into that in more detail in the article. But with the caveat, a lot of this article is about limitations, and the data that we have to talk about increased risk of recurrence was based off seeing epileptic form discharges on routine EEG. So you could hypothesize that if you only have one epileptic form discharge in three days on an ambulatory EEG, that may not carry the same recurrent significance as catching one on a twenty minute EEG. But we don't have that knowledge. Dr Grouse: Getting a little bit more into what you mentioned about the limitations, when is the scalp EEG less useful or limited in the evaluation of epilepsy? Dr Weber: So, one thing I see a lot in my residence at here and other places where I've worked is, I get them very excited about EEG and they may order it a bit too much. So, if patients have a known, established diagnosis of epilepsy, electrographically confirmed, and they come in with a breakthrough seizure and they're back to their baseline, there's really not a strong reason to get an EEG. We often seem to in the emergency department as part of our evaluation, but we already know what happened to the patient. The patient's not doing poorly right now, so the EEG is not going to give you any additional information. Just like really any test, you should think, what are the possible outcomes of this test and how would those outcomes alter the care of this patient? And if no outcome is going to affect the care of the patient or give you any additional diagnostic information, then probably don't need to be doing that test. Dr Grouse: This is probably a good segue into asking, what is an area of confusion or common pitfalls that you've seen in the clinical application of EEG and epilepsy? Dr Weber: So, a lot of times on the inpatient service, we'll get longer-term EEGs for patients who are having spells that are occurrent while they're in the ICU or other places or altered in some way, encephalopathic. And these patients will have their spell, and in my report, I'll say that there is not any electrographic correlate. So, there's no EEG finding that goes along with the movement that they're doing that's concerning for a seizure. And that doesn't always mean that it's not an epileptic seizure. An EEG is not a one-hundred-percent tool. Epilepsy and seizures are a clinical diagnosis. The EEG is a helpful tool to guide that diagnosis, but it is not foolproof, so you need to take the whole clinical picture into account. Particularly focal seizures without impaired awareness often can be electrographically silent on surface EEG. If you see something that looks clinically like a seizure but doesn't show up on the EEG, there are circumstances that they get to in the paper a little bit where that can still be an epileptic seizure. And you just have to be aware of the limitations of the tests that you're ordering and always fall back on the clinical skills that you've learned. Dr Grouse: Are there any tips or tricks you can suggest to improve the clinical utility of EEG for diagnosis of epilepsy? And also thinking about the example you just gave, but maybe other cases as well? Dr Weber: Again, definitely need to incorporate EEG as part of a larger picture. The video component of EEG is incredibly helpful. You can't interpret EEG in isolation. Regardless of what the EEG shows, you can't make a diagnosis of epilepsy, but you certainly can be very suspicious of one. So, in those cases where you have a high suspicion for an epileptic seizure and the EEG has not given you any confirmatory evidence, it's really helpful to rely on any clinical expertise that you have access to. So, people who have seen lots of seizures may be helpful in that situation. Getting good recordings, good data to prove yourself one way or the other is helpful and continuing to evaluate. So usually, as I said, focal seizures that don't show up well on the EEG. People who have focal seizures will often have larger seizures if left untreated. So, you can try to admit them to an epilepsy monitoring unit where we try to provoke seizures and try to provoke a larger seizure to help confirm that diagnosis. Dr Grouse: This kind of gets into what we've already reviewed to some degree, but what is the easiest mistake to make (and hopefully avoid) when using EEG to diagnose epilepsy or make other treatment decisions? Dr Weber: I think the easiest, most common mistake I see is overreliance on the test. There's a lot of subjectivity to the interpretation of this test. There are a lot of studies out there on interrater reliability for epilepsy and intrarater reliability for epilepsy. We continue to try to make the findings more objective and get more quantified. The articles talk about our six criteria for epileptiform discharges and have reference to where that came from and the sorts of specificity that each of those criteria lead to. Just because an EEG report has said something, that does not diagnose or negate a clinical diagnosis of epilepsy. It is common for folks with non-epileptic seizures to have a history of reported epileptic form discharges on their EEG. Again, because there is some subjectivity to the test, some abnormal-looking normal variants will pop up and get interpreted as epileptiform discharges. It's important to review the whole patient, as much of the data as you can, and make the best clinical judgment you can of the overall case. Dr Grouse: What is quantitative EEG and how can it be clinically useful? Dr Weber: Now that most EEG is obtained digitally through the use of computer software, we have been able to employ computers to do a lot of the work for us. There are many different ways of looking at the EEG data, but it's all frequency bands over time. The quantitative EEG goal is really to simplify and condense what you're seeing on your normal EEG page into a more digestible format. Lets you look at a larger amount of data faster, which becomes more and more important as we're doing more of these long-term recordings, particularly in the intensive care unit. Quantitative EEG can help you assess a lot of data at a snapshot and get a general sense of what's going on with the patient over the past several hours. It does require some extra training to become familiar with it, but it's training that can be done at all levels. Again, it can help you see more, faster. Obviously, like everything, it has its own limitations. Sometimes the sensitivity and specificity may be a little off from the raw data review, and you should always go back to the raw data anytime there are questions. But it can be helpful to make things faster. Dr Grouse: Do you think you could give me a hypothetical example of a case where this would be something really nice to have?  Dr Weber: The most common example is folks with repetitive seizures in the ICU. If you're just looking at the raw data, you will get a sense of how often the seizures are happening. But if you look at the quantitative data, it sort of compresses that all down to a much smaller snapshot. So you can see much more readily, yes, these are how many seizures were happening. And here's where we gave our intervention; and look, there are fewer seizures after that intervention. So, it can help you assess response to treatment, help you assess just overall volume of seizures in a much more condensed fashion, and you can get through it much faster with the appropriate training. Dr Grouse: Can you tell us about any new developments in EEG that are on the horizon we should be aware of?  Dr Weber: Yeah. So, I think my two favorites, which I highlight in the article, are longer-term recordings---so, there's some companies that are working on subcutaneous EEG. So, implanted EEG electrodes that can stay in your body for the short, long term on the order of year or years and constantly send some EEG data. Obviously, it's not a full montage in most of those cases, but some EEG data that can help you assess long-term trends in epilepsy and long-term response to therapies. I think that's going to be really cool. I think it's very exciting and I think it'll change how we do clinical trials in the future. I think we'll be able to rely less on seizure diaries from folks and more on objective seizure data for patients who have these implanted. But with that will come an ever-increasing amount of data to be reviewed, which leads into the other exciting future trend is AI in the use of interpretations. AI is becoming more and more advanced and there are very exciting articles out on how good AI is getting at interpreting our EEGs. I think soon, in the very near future, the AI platforms will be able to dramatically reduce the amount of time it takes the experts to review an EEG. They'll be able to do a lot of the screening for us and then we can go back, just like I was talking about the quantitative EEG, go back and review segments of the raw data rather than having to review every page of every file, which is quite time consuming. Dr Grouse: Wow, that's really exciting. It certainly does seem like AI is making breakthroughs in just about every area of how we touch the practice of medicine. Exciting to hear that EEG is no exception. Dr Weber: Yeah, I'm fully excited. I think it's going to revolutionize what we're doing and also just greatly expand people's ability to access that level of expertise that the AI will offer. Dr Grouse: I wanted to transition to talking a little bit more about you and your career in neurology. How did you become interested in this area of neurology to begin with? Dr Weber: Yeah, it's sort of a roundabout fashion. So, I started out planning to be a neurointerventionalist, and then I realized that I didn't want that sort of call. For a hot minute in my PGI 3 year. I was planning to be a neuro-ICU doctor. I think that's largely because medicine is all I had been exposed to at that point and the ICU seemed like a very comfortable place. Then as I transitioned into PGI 3 we started doing more electives and outpatient rotations in my residency. And then I was planning on being a movement disorder specialist or an epileptologist, couldn't make up my mind for the longest time. And then I started to like EEG more than I liked watching videos. So, tilted myself towards epilepsy and haven't looked back.  Dr Grouse: Well, I really appreciated you coming to talk with us today about your article. I can't recommend it enough to anyone out there, whoever treats patients with epilepsy or orders the EEGs, I just think it was just incredibly useful. And it was such a pleasure to have you. Dr Weber: Thank you very much for having me, Katie.  Dr Grouse: Again, today I've been interviewing Dr Daniel Weber about his article on EEG and epilepsy, which appears in the most recent issue of Continuum on Epilepsy. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use this link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.  

The Ugly Dog Podcast
38. Jake Faas - Marrying Into Grouse Hunting, The Importance of Managing Your Dogs, and His Journey From Bite Dogs to Bird Dogs.

The Ugly Dog Podcast

Play Episode Listen Later Jan 9, 2025 86:35


Jake Faas of True Loyalty Dog Training joins the show this week to share how he fell in love with dogs doing bite sports and training working dogs and then through marriage came to upland hunting and owning French Brittanies. Jake is an experience bite dog trainer and decoy, but never hunted until his father-in-law told him he wasn't a member of the family until he killed a grouse. After that the rest was history.This episode contains a ton of gems for the avid bird dogger and trainer.Enjoy!This episode is brought to you by Ugly Dog Hunting Co. Shop now at UglyDogHunting.com.Music used under Creative Commons -Two Step Daisy Duke by Mr. Smith is licensed under an Attribution 4.0 International License.

BirdNote
Of Grouse and Gizzards

BirdNote

Play Episode Listen Later Jan 4, 2025 1:45


During winter, the Greater Sage-Grouse is wholly reliant on its namesake species — sagebrush — for both shelter and for food. Scientists call this bird "sagebrush obligate," meaning it needs this plant to survive. In the spring, its diet shifts to insects and plants, as it gets ready for the most fantastic mating show in the west — the lekking season.More info and transcript at BirdNote.org. Want more BirdNote? Subscribe to our weekly newsletter. Sign up for BirdNote+ to get ad-free listening and other perks. BirdNote is a nonprofit. Your tax-deductible gift makes these shows possible. 

BirdNote
Spruce Grouse – Perfect for the Boreal Forest

BirdNote

Play Episode Listen Later Dec 17, 2024 1:45


In the boreal forest, winter temperatures routinely drop to 30 degrees below zero. Birds that spend the winter in this harsh domain rely on remarkable adaptations to survive. The Spruce Grouse is one such bird. Most Spruce Grouse remain here all year. In the snow-free summer, they forage on the ground, eating fresh greenery, insects, and berries. But in the snowy winter, the grouse live up in the trees, eating nothing but conifer needles. Lots and lots of needles. Because conifer needles are both low in protein and tough to digest, Spruce Grouse grow a bigger digestive system. A grouse's gizzard, which grinds food, may enlarge by 75%!More info and transcript at BirdNote.org. Want more BirdNote? Subscribe to our weekly newsletter. Sign up for BirdNote+ to get ad-free listening and other perks. BirdNote is a nonprofit. Your tax-deductible gift makes these shows possible. 

On The Wing Podcast
EP. 294: A Masterclass in Prairie Grouse

On The Wing Podcast

Play Episode Listen Later Nov 18, 2024 63:36


This is the fourth episode of Pheasants Forever's 15th annual Rooster Road Trip. Host Bob St.Pierre is joined by PF's Vice President of Marketing Andrew Vavra and University of North Dakota's Dr. Susan Felege. Dr. Felege is a professor of wildlife biology & management and is also a member of PF & QF's National Board of Directors. Episode Highlights: • Dr. Felege recounts the history of prairie grouse populations across North Dakota and provides a status report for how sharp-tailed grouse and greater prairie chickens are currently doing in the state. • Vavra talks about “the pucker factor” of hunting in a region where greater prairie chickens and hen pheasants are illegal to shoot, while sharp-tailed grouse and sharpie/chicken hybrids are both legal. • Dr. Felege also shares her enthusiasm for working with the Grand Forks County Prairie Partners and how the collection of non-profit groups, state and federal agencies, farmers, and volunteers are helping conserve this very special tall grass prairie. • Find the companion video accompanying this podcast episode at www.RoosterRoadTrip.org. While there, enter to win a Browning Citori 825 shotgun and join/renew/extend your Pheasants Forever or Quail Forever membership featuring the new Browning Bird & Buck knife. And special thanks to our Rooster Road Trip 2024 sponsors • Browning • Orvis • SoundGear • Ruff Land Kennels • Federal Ammunition • Garmin • YETI • Irish Setter onX Hunt is a proud supporter of Pheasants Forever and Quail Forever and they want to thank everyone who gives back to the birds we all love to hunt and the places they call home. Click this link to get a free month of onX Hunt and then use code PFQF to get 20% off, and a portion will go back to supporting Pheasants Forever and Quail Forever's wildlife habitat mission.

Project Upland Podcast
#296 | A Walk Through the Grouse Woods with Bob Owens

Project Upland Podcast

Play Episode Listen Later Nov 15, 2024 88:54


Joined by Bob Owens of Lone Duck, we discuss a recent ruffed grouse hunt, a cross country bird hunting trip, bird dogs and more. Show Highlights: Duck and goose hunting the great plains Scouting for cover and access in a new state Have you ever seen the northern lights IRL? Attending the Grand National Grouse Championship in Wisconsin Scouting and exploring ruffed grouse habitat Getting a young puppy on grouse Bird dogs naturally backing or not… Nick and Bob take a walk through the grouse woods 2025 St. Hubtert's Trial - Cheraw, SC SUPPORT | patreon.com/birdshot Follow us | @birdshot.podcast Use Promo Code | BSP20 to save 20% with onX Hunt Use Promo Code | BP15 to save 15% on Marshwear Clothing Use Promo Code | BSP10 to save 10% on Trulock Chokes The Birdshot Podcast is Presented By: onX Hunt, Final Rise and Upland Gun Company Learn more about your ad choices. Visit megaphone.fm/adchoices

Project Upland Podcast
#293 | Great Lakes Grouse Hunting Trip Update with Nick Adair

Project Upland Podcast

Play Episode Listen Later Oct 25, 2024 99:31


Joined by Nick Adair of the Gun Dog It Yourself Podcast, we recap some recent hunts and get an update from Nick and his dogs on his multi-state ruffed grouse hunting road-trip. Show Highlights: Great Lakes grouse woods report “What seriously happened last night?” Where are all the woodcock? Making memories with aging bird dogs Puppy walks and porcupines Rooftop tents and camping set-ups  The Bird Dog Society St Huberts Trial Ruffed grouse patterns and food sources LISTEN | Gun Dog It Yourself Podcast SUPPORT | patreon.com/birdshot Follow us | @birdshot.podcast Use Promo Code | BSP20 to save 20% with onX Hunt Use Promo Code | BP15 to save 15% on Marshwear Clothing Use Promo Code | BSP10 to save 10% on Trulock Chokes The Birdshot Podcast is Presented By: onX Hunt, Final Rise and Upland Gun Company Learn more about your ad choices. Visit megaphone.fm/adchoices

Project Upland Podcast
#290 | Ann Jandernoa Answers Your Grouse and Woodcock Questions Part 2

Project Upland Podcast

Play Episode Listen Later Sep 27, 2024 81:08


Joined once again by Ann Jandernoa we answer listener questions on all things grouse and woodcock hunting during part two of our annual conversation. Show Highlights: How might wet spring conditions affect grouse nesting and brooding? Checking rainfall amounts in your area - VegDRI Index Hunting pressured grouse Do woodcock run more than they used to? What kind of hunting boots do you like?  Check out the Hunt the Habitat Podcast Binge listen to Ann on grouse and woodcock: 2017 - Episode #7 2018 - Episode #42 2019 - Episode #76 2020 - Episode #115 2021 - Episode #150 2022 - Episode #190 2023 - Episode #239 and #240 2024 - Episode #289 MAP | with Scout N Hunt SUPPORT | patreon.com/birdshot Follow us | @birdshot.podcast Use Promo Code | BSP20 to save 20% with onX Hunt Use Promo Code | BSP15 to save 15% on Marshwear Clothing Use Promo Code | BSP10 to save 10% on Trulock Chokes The Birdshot Podcast is Presented By: onX Hunt, Final Rise and Upland Gun Company Learn more about your ad choices. Visit megaphone.fm/adchoices

The Hunting Dog Podcast
Everything you ever wanted to know about grouse and woodcock

The Hunting Dog Podcast

Play Episode Listen Later Sep 6, 2024 57:28


A celebration in the woods! Its the kickoff for Michigan grouse season. If you want to learn what it takes to hunt grouse, or just want to hang out with a bunch like minded folks, this ones for you!